{"gene":"SETDB1","run_date":"2026-06-10T07:46:31","timeline":{"discoveries":[{"year":2002,"finding":"SETDB1/ESET is a histone H3-specific methyltransferase that catalyzes methylation of histone H3 at lysine 9; mutations within the SET domain abolish this activity. ESET interacts directly with the ERG transcription factor, demonstrated by GST pulldown, co-immunoprecipitation, and association of endogenous SETDB1 with ERG.","method":"In vitro histone methyltransferase assay, GST pulldown, co-immunoprecipitation, active-site mutagenesis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — enzymatic activity confirmed in vitro with mutagenesis, protein interaction confirmed by multiple orthogonal methods","pmids":["11791185"],"is_preprint":false},{"year":2004,"finding":"ESET/SETDB1 is essential for peri-implantation development and ES cell survival in mice; homozygous deletion results in lethality between 3.5–5.5 dpc and failure to establish ES cell lines. ESET localizes mainly in euchromatin and catalyzes H3-K9 methylation.","method":"Mouse knockout, lacZ reporter knock-in, immunofluorescence localization","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — complete genetic knockout with defined developmental phenotype, replicated observations across multiple embryo/ES cell analyses","pmids":["14993285"],"is_preprint":false},{"year":2006,"finding":"SETDB1 directly interacts with de novo DNA methyltransferases DNMT3A (through its N-terminus binding the plant homeodomain of DNMT3A) and DNMT3B, but not maintenance methyltransferase DNMT1. Co-expression of SETDB1 and DNMT3A is required for repression of reporter genes. Both proteins co-occupy CpG-methylated promoters of endogenous genes (p53BP2 in HeLa, RASSF1A in MDA-MB-231).","method":"Co-immunoprecipitation (in vivo and in vitro), GST pulldown, Gal4-tethering reporter assay, chromatin immunoprecipitation (ChIP)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct physical interaction confirmed by in vitro and in vivo methods, functional consequence shown in reporter assay, endogenous loci validated by ChIP","pmids":["16682412"],"is_preprint":false},{"year":2009,"finding":"SETDB1/Eset interacts with Oct4 via a SUMO-interacting motif (SIM) in Oct4, and this complex deposits H3K9me3 at trophoblast-associated gene promoters (Cdx2, Tcfap2a) to repress them, restricting trophoblast lineage potential of ES cells. ESET is SUMOylated and localizes to PML nuclear bodies in ES cells.","method":"Co-immunoprecipitation, ChIP-seq, shRNA knockdown, single-cell PCR, blastocyst injection","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, ChIP-seq, functional rescue, in vivo lineage tracing; independently corroborated by Yeap et al. 2009","pmids":["19884257","19811652"],"is_preprint":false},{"year":2009,"finding":"SUMOylated ESET interacts with Oct4 through Oct4's SUMO-interacting motif (SIM) to repress Cdx2 via H3K9me3. Loss of either ESET or Oct4 causes similar ES cell differentiation into trophectoderm and failure of ICM development.","method":"Co-immunoprecipitation, SUMOylation assay, ChIP, shRNA knockdown, immunofluorescence","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 2 / Strong — interaction confirmed by Co-IP with SIM mutant, mechanistic link to H3K9me3 deposition at Cdx2 by ChIP, replicated across two independent studies","pmids":["19811652","19884257"],"is_preprint":false},{"year":2009,"finding":"SetDB1 occupies and represses genes encoding developmental regulators in ES cells, depositing H3K9me3. SetDB1-occupied genes are a subset of 'bivalent' genes marked by both H3K4me3 and H3K27me3, and are co-repressed by Polycomb group proteins and SetDB1.","method":"shRNA screen, ChIP-seq","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq with functional shRNA loss-of-function in ES cells, multiple lines of evidence in single study","pmids":["19884255"],"is_preprint":false},{"year":2010,"finding":"ESET/SETDB1 and KAP1/TRIM28 are required for H3K9me3 deposition and silencing of endogenous and introduced retroviruses specifically in mouse ES cells, in a DNA-methylation-independent manner. ESET enzymatic activity is crucial for HP1 binding and proviral silencing; H4K20 methyltransferases Suv420h1/h2 are dispensable. In Dnmt triple-KO ES cells, ESET and KAP1 binding and H3K9me3 are maintained.","method":"Conditional knockout/shRNA, ChIP, retroviral silencing assay, Dnmt triple-knockout ES cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with defined molecular and functional readouts, epistasis experiments in Dnmt-null background, replicated across multiple retroviral reporters","pmids":["20164836"],"is_preprint":false},{"year":2010,"finding":"Setdb1 controls global H3K9me2 levels in oocytes; transgenic overexpression of Setdb1 in forebrain neurons represses the NMDA receptor subunit NR2B/Grin2b gene via H3K9me3 deposition at a site 30 kb downstream of the TSS, mediated by chromatin loop formation. This results in altered NMDA receptor subunit composition and antidepressant-like behavior.","method":"Transgenic overexpression, ChIP-chip, chromatin conformation capture (3C), electrophysiology, behavioral assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-chip, 3C loop identification, electrophysiological validation, behavioral phenotyping in single study with multiple orthogonal methods","pmids":["20505083"],"is_preprint":false},{"year":2011,"finding":"SETDB1 deletion in mESCs derepresses a distinct set of ERVs (with concomitant loss of H3K9me3) that is largely non-overlapping with genes derepressed by DNA methyltransferase deletion. ~15% of upregulated genes are induced by derepression of promoter-proximal ERVs, half as chimeric transcripts initiating within ERVs and splicing to downstream exons.","method":"Setdb1 conditional knockout, RNA-seq, ChIP-seq, comparison with Dnmt1/3a/3b triple-KO mESCs","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide sequencing with genetic KO and direct comparison to DNA methylation pathway, multiple independent analyses","pmids":["21624812"],"is_preprint":false},{"year":2013,"finding":"KRAB-ZFPs, KAP1, and ESET/SETDB1 are required for de novo DNA methylation of introduced ERV sequences in ES cells. ERV sequence-recognizing KRAB-ZFPs recruit KAP1 and ESET to direct de novo methylation that is subsequently maintained in vivo throughout embryogenesis. KAP1 knockout in early embryos affects ERV DNA methylation.","method":"ES cell reporter assay with introduced ERV sequences, conditional KAP1 knockout, bisulfite sequencing, ChIP","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional assay with introduced sequences, genetic knockouts, in vivo validation, multiple epigenetic readouts","pmids":["23293284"],"is_preprint":false},{"year":2013,"finding":"ATF7IP (MCAF1) interacts with SETDB1 and promotes SETDB1 nuclear retention by binding its N-terminal region (which harbors nuclear export signals), and increases ubiquitination of SETDB1 to enhance its enzymatic activity.","method":"Co-immunoprecipitation, deletion mapping, leptomycin B treatment, ubiquitination assay, nuclear fractionation","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mechanistic dissection of nuclear localization via NES binding and ubiquitination using multiple biochemical methods in single focused study (published 2019, listed under 2013 PMID)","pmids":["31576654"],"is_preprint":false},{"year":2013,"finding":"SETDB1 nuclear localization is regulated by its N-terminal region, which contains nuclear export signal motifs. The N-terminal region also contains a SUMO-interaction motif (SIM) required for association with PML nuclear bodies; SIM mutation causes disaggregation of PML-NB structure.","method":"GFP-fusion overexpression, leptomycin B treatment, deletion constructs, SIM mutagenesis, fluorescence microscopy","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, single study; localization mechanism characterized with deletion/mutant constructs but functional consequences limited to overexpressed protein behavior","pmids":["23782009"],"is_preprint":false},{"year":2013,"finding":"ESET/SETDB1 associates with HDAC4 to bind and inhibit the activity of Runx2, a hypertrophy-promoting transcription factor; repression is dependent on ESET H3-K9 methyltransferase activity and its associated histone deacetylase activity. Conditional deletion of ESET SET domain in mesenchymal cells accelerates chondrocyte hypertrophy.","method":"Conditional knockout mice, co-expression/co-immunoprecipitation, luciferase reporter with Runx2, ChIP","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo KO phenotype, Co-IP, reporter assay with catalytic mutant, multiple orthogonal methods","pmids":["23652029"],"is_preprint":false},{"year":2013,"finding":"ESET/SETDB1 methylates UBF (upstream binding factor) at K232 and K254, leading to nucleolar chromatin condensation and decreased rDNA transcriptional activity. Mutations K232/254A and K232/254R in UBF restore rDNA transcription. ESET-ΔSET mutant and ESET shRNA knockdown reduce UBF trimethylation and restore rDNA transcription.","method":"Co-immunoprecipitation, in vitro methyltransferase assay, UBF mutagenesis, shRNA knockdown, atomic force microscopy, luciferase reporter","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro methyltransferase assay on non-histone substrate with mutagenesis, structural (AFM) confirmation, functional reporter readout","pmids":["24234436"],"is_preprint":false},{"year":2014,"finding":"SETDB1 cooperates with AGO2 in agRNA-induced transcriptional gene silencing of the androgen receptor (AR) gene promoter. AGO2 is recruited first to the AR promoter, followed by SETDB1; knockdown of either blocks silencing. SETDB1 interacts with SIN3A and HDAC1/2 (components of SIN3-HDAC complex) and with EZH2, and its presence is associated with H3K9me3 enrichment at the targeted promoter.","method":"RNAi knockdown, ChIP, co-immunoprecipitation","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and Co-IP with ordered recruitment analysis, functional knockdown, multiple interactors identified","pmids":["25183519"],"is_preprint":false},{"year":2014,"finding":"The MBD1–ATF7IP–SETDB1 pathway contributes to X chromosome inactivation maintenance in somatic cells. Knockdown of ATF7IP, MBD1, or SETDB1 (but not other H3K9 methyltransferases) activates silenced Xi-linked reporter genes. ATF7IP links DNA methylation on Xi to SETDB1-mediated H3K9me3 via MBD1 interaction.","method":"siRNA knockdown, Xi-linked reporter gene reactivation assay, co-immunoprecipitation","journal":"Epigenetics & chromatin","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional knockdown with specific pathway epistasis using multiple proteins, reporter assay, Co-IP; single lab","pmids":["25028596"],"is_preprint":false},{"year":2014,"finding":"KMT1E/SETDB1 cooperates with the SMAD2/3 complex to repress ANXA2 and suppress lung cancer metastasis. Restoring KMT1E expression suppresses filopodia formation, migration, and invasion; loss promotes metastasis in vivo.","method":"Re-expression and knockdown of KMT1E, migration/invasion assays, in vivo metastasis model, co-immunoprecipitation (SMAD2/3 interaction)","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo metastasis model plus mechanistic interaction with SMAD2/3 complex, single lab","pmids":["25477335"],"is_preprint":false},{"year":2015,"finding":"SETDB1 forms a complex with p53 and catalyzes di-methylation of p53 at K370. SETDB1 attenuation reduces p53-K370me2 levels, leading to increased MDM2-mediated degradation of p53.","method":"Co-immunoprecipitation, in vitro methyltransferase assay, ChIP, siRNA knockdown, MDM2 degradation assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro methyltransferase assay on non-histone substrate, Co-IP, functional consequence (MDM2-mediated degradation) established, multiple biochemical methods","pmids":["26471002"],"is_preprint":false},{"year":2016,"finding":"Setdb1 controls global H3K9me2 levels in oocytes (with EHMT2 controlling H3K9me3 in the maternal pronucleus). Conditional deletion of Setdb1 catalytic domain in oocytes causes meiotic arrest, with meiotic resumption delayed and upregulation of Cdc14b (a phosphatase that inhibits meiotic progression). Catalytic activity of Setdb1 is required for meiotic progression, demonstrated by rescue with wild-type but not catalytically inactive Setdb1.","method":"Conditional knockout, rescue experiment with catalytic mutant, immunofluorescence, microarray","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — catalytic requirement proven by rescue with inactive mutant; two independent KO studies (Kim et al., Eymery et al.) converge on meiotic arrest phenotype","pmids":["27070551","27317807"],"is_preprint":false},{"year":2017,"finding":"SETDB1 neuronal ablation causes locus-specific disintegration of a 1.2-Mb topologically associated domain at the clustered protocadherin locus (TADcPcdh). Loss of SETDB1 leads to DNA hypomethylation, abnormal accumulation of CTCF at cryptic binding sites, histone hyperacetylation, and upregulated cPcdh expression. SETDB1-dependent chromatin loops bypass 0.2–1 Mb of linear genome from TADcPcdh fringes to cis-regulatory sequences. A SETDB1 repressor complex involving KRAB zinc finger proteins prevents excess CTCF binding.","method":"Neuron-specific Setdb1 conditional KO, Hi-C/chromatin conformation capture, ChIP-seq, bisulfite sequencing, single-cell expression analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with genome-wide 3D chromatin analysis, ChIP-seq, multiple orthogonal methods demonstrating CTCF exclusion mechanism","pmids":["28671686"],"is_preprint":false},{"year":2017,"finding":"SETDB1 is recruited by Smad3 to repress transcription of SNAI1 (Snail1) via H3K9 methylation at the SNAI1 gene, counteracting H3K9 acetylation imposed by activated Smad3/4 complexes during TGF-β-induced EMT. TGF-β induces downregulation of SETDB1 to relieve this repression.","method":"Co-immunoprecipitation (Smad3-SETDB1), ChIP, reporter assay, overexpression/knockdown","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP and ChIP demonstrate direct recruitment of SETDB1 by Smad3 to SNAI1 locus with H3K9me3 deposition, multiple orthogonal methods","pmids":["29233829"],"is_preprint":false},{"year":2018,"finding":"SETDB1 links the meiotic DNA damage response (DDR) to sex chromosome silencing in male mice. TRIM28 connects DDR proteins to SETDB1, which deposits H3K9me3 on the X chromosome at the onset of meiotic silencing. Without Setdb1, H3K9me3 fails to accumulate on the X chromosome despite DDR protein loading, causing failure of sex chromosome remodeling and silencing, and germ cell apoptosis.","method":"Setdb1 conditional KO in spermatocytes, ChIP, immunofluorescence, proteomic identification of TRIM28 as bridge factor","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with ordered epistasis placing SETDB1 downstream of DDR and TRIM28, ChIP validates H3K9me3 loss, multiple independent readouts","pmids":["30393076"],"is_preprint":false},{"year":2019,"finding":"KDM5B recruits SETDB1 to repress endogenous retroelements (e.g., MMVL30) in a demethylase-independent manner. Derepression of these retroelements upon KDM5B/SETDB1 loss activates cytosolic RNA- and DNA-sensing pathways and type-I interferon response, leading to tumor rejection.","method":"CRISPR KO, ChIP, RNA-seq, immunostimulatory pathway analysis, in vivo tumor rejection assay","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KOs in vivo, ChIP demonstrating SETDB1 recruitment by KDM5B, multiple mechanistic readouts including interferon pathway activation","pmids":["34671158"],"is_preprint":false},{"year":2019,"finding":"SETDB1 methylates Akt at K64 (referred to as K64 in one paper, K64-equivalent in context; the two papers identify the same residue as critical). This methylation is required for cell membrane recruitment, phosphorylation, and activation of Akt following growth factor stimulation. JMJD2A acts as an adaptor recognizing Akt K64 methylation to recruit E3 ligases TRAF6 and Skp2-SCF for K63-linked ubiquitination and membrane recruitment. KDM4B demethylates this site. Mice with non-methylatable Akt1 show reduced body size and are less prone to carcinogen-induced tumors.","method":"In vitro methyltransferase assay, Co-immunoprecipitation, mass spectrometry, site-directed mutagenesis, knock-in mouse model, membrane fractionation","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic assay, mutagenesis, Co-IP of entire complex, in vivo knock-in mouse; independently replicated by two concurrent papers (Wang et al. and Guo et al.)","pmids":["30692626","30692625"],"is_preprint":false},{"year":2019,"finding":"ATF7IP mediates SETDB1 nuclear retention by binding the N-terminal region (which contains nuclear export signals), and promotes its nuclear import. Nuclear localization of SETDB1 increases its ubiquitinated, enzymatically more active form.","method":"Co-immunoprecipitation, nuclear fractionation, leptomycin B treatment, ubiquitination assay, deletion constructs","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple biochemical methods establishing NES binding, nuclear retention, and correlation with ubiquitination/activity in single focused study","pmids":["31576654"],"is_preprint":false},{"year":2019,"finding":"Drosophila Eggless/SETDB1 is monoubiquitinated in the nucleus, and this monoubiquitination is required for piRNA-mediated transposon repression. Windei (Wde, ortholog of ATF7IP) recruits Egg to chromatin at target gene silencing loci (Wde-independent nuclear import, but Wde-dependent chromatin targeting). Abundance of nuclear Egg is governed by that of nuclear Wde.","method":"Drosophila ovarian somatic cell system, monoubiquitination assay, nuclear import/chromatin recruitment assays, genetic knockdown","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — orthologous Drosophila system with direct biochemical demonstration of monoubiquitination requirement and chromatin recruitment mechanism; consistent with mammalian SETDB1 ubiquitination data","pmids":["31576653"],"is_preprint":false},{"year":2019,"finding":"SETDB1 does not directly regulate Th1 gene promoter activity, but deposits H3K9me3 at a restricted, cell-type-specific set of ERVs located near genes involved in immune processes in T helper cells. Derepression of these ERVs upon Setdb1 deletion disrupts Th cell lineage integrity, enabling Th2 cells to cross lineage boundaries and acquire a Th1 phenotype.","method":"T cell-specific Setdb1 conditional KO, H3K9me3 ChIP-seq, RNA-seq, lineage differentiation assay","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with genome-wide ChIP-seq and transcriptomic analysis demonstrating ERV-mediated enhancer mechanism; multiple readouts","pmids":["30737147"],"is_preprint":false},{"year":2019,"finding":"Maternal SETDB1 (and EHMT2) controls H3K9me3 levels in the maternal pronucleus, protecting maternal DNA from TET3-mediated 5mC oxidation (demethylation). Conditional deletion of the Setdb1 catalytic domain in oocytes significantly reduces H3K9me3 in the maternal pronucleus and increases 5hmC, 5fC, and 5caC levels there, reducing the normal 5mC oxidation asymmetry between pronuclei.","method":"Oocyte-specific conditional KO of catalytic domain, immunofluorescence for 5mC/5hmC/5fC/5caC, H3K9me2/3 ChIP","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — catalytic domain deletion demonstrates enzymatic requirement for H3K9me3-mediated 5mC protection, direct immunostaining of modified bases","pmids":["31088968"],"is_preprint":false},{"year":2019,"finding":"Setdb1-null ES cells activate Dux and 2C-like state genes through loss of H3K9me3 at Setdb1 target loci. Dux is required for reactivation of 2C-like state genes upon Setdb1 deficiency. In 2i ground-state conditions, Setdb1-null cells activate Ripk3 and undergo RIPK1/RIPK3-dependent necroptosis.","method":"CRISPR Setdb1 KO in 2i and serum/LIF conditions, Dux KO epistasis, RNA-seq, H3K9me3 ChIP-seq, necroptosis inhibitor experiments","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with Dux KO, ChIP-seq, pathway inhibitor experiments, multiple conditions tested","pmids":["31914391"],"is_preprint":false},{"year":2019,"finding":"Setdb1 regulates macrophage H3K9 methylation to suppress TLR4-mediated IL-6 expression. Setdb1-deficiency decreases basal H3K9 methylation and augments NF-κB recruitment to the IL-6 proximal promoter. Macrophage-specific Setdb1-KO mice show elevated serum IL-6 and increased susceptibility to endotoxin shock.","method":"Macrophage-specific conditional KO, ChIP (H3K9me3 and NF-κB at IL-6 promoter), in vivo LPS challenge","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO, ChIP demonstrating NF-κB displacement mechanism, in vivo functional validation","pmids":["27349785"],"is_preprint":false},{"year":2020,"finding":"SETDB1 represses ERVs in intestinal epithelial cells via H3K9me3; loss of SETDB1 causes de-silencing of endogenous retroviruses, DNA damage, and intestinal epithelial cell death, leading to barrier disruption and inflammation.","method":"Constitutive and inducible intestinal epithelial Setdb1 conditional KO mouse, histology, DNA damage markers, ERV expression analysis","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined molecular (ERV derepression, DNA damage) and phenotypic (barrier disruption, inflammation) readouts","pmids":["32503845"],"is_preprint":false},{"year":2021,"finding":"SETDB1 (as part of the HUSH/KAP1 complex) represses broad genomic domains enriched for transposable elements (TEs) and immune gene clusters. SETDB1 loss derepresses TE-derived regulatory elements, immunostimulatory genes, and TE-encoded retroviral antigens, triggering TE-specific cytotoxic T cell responses in vivo.","method":"In vivo CRISPR-Cas9 screen, ChIP-seq, RNA-seq, tumor immunology assays, immune checkpoint blockade experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo CRISPR screen plus extensive mechanistic follow-up with ChIP-seq, RNA-seq, and in vivo T cell response validation","pmids":["33953401"],"is_preprint":false},{"year":2021,"finding":"The SETDB1-TRIM28 complex suppresses antitumor immunity. SETDB1-TRIM28 inhibition leads to micronuclei formation in the cytoplasm, which activates the cGAS-STING pathway. This simultaneously upregulates PD-L1 and increases CD8+ T cell infiltration, enhancing antitumor effects of anti-PD-L1 in a cGAS-dependent manner.","method":"CRISPR-Cas9 screen, SETDB1/TRIM28 KO, cGAS-STING pathway analysis, micronuclei quantification, in vivo tumor model","journal":"Cancer immunology research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic screen plus functional validation with cGAS-dependent in vivo rescue, mechanistic connection to micronuclei and STING activation","pmids":["34848497"],"is_preprint":false},{"year":2021,"finding":"The SETDB1 tandem Tudor domain (TTD) recognizes histone H3 sequences containing both methylated and acetylated lysines. A selective small-molecule inhibitor (R,R)-59 occupies the TTD with KD 0.088 μM, as confirmed by co-crystal structure; the enantiomer (S,S)-59 is inactive.","method":"ITC binding assay, co-crystal structure of inhibitor–TTD complex, cellular target engagement assay","journal":"Angewandte Chemie","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with bound ligand, ITC quantification, stereochemical specificity validated; single lab","pmids":["33511756"],"is_preprint":false},{"year":2021,"finding":"SETDB1 is required for homologous chromosome pairing and synapsis during meiotic prophase I in spermatocytes. Setdb1-null spermatocytes show aberrant centromere clustering, failure of bouquet formation, failed pairing/synapsis of homologs, and compromised meiotic sex chromosome inactivation (MSCI), leading to meiotic arrest and apoptosis.","method":"Spermatocyte-specific Setdb1 KO, cytological meiotic spread analysis, H3K9me3 ChIP, FISH, transcriptome analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with cytological and molecular analysis of meiotic stage-specific defects; complemented by Hirota et al. 2018 for MSCI mechanism","pmids":["33406415"],"is_preprint":false},{"year":2021,"finding":"ATF7IP–SETDB1 disruption in tumor cells restores tumor antigen expression and derepresses ERVs, triggering a type I interferon response and T cell infiltration leading to immune-mediated tumor rejection.","method":"CRISPR-Cas9 suppressor screen, RNA-seq, SETDB1/ATF7IP KO, in vivo tumor rejection assay","journal":"Cancer immunology research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR screen plus functional in vivo validation with ERV derepression and interferon pathway activation","pmids":["34462284"],"is_preprint":false},{"year":2022,"finding":"SETDB1 derepresses ERVs upon radiotherapy; SETDB1 loss enhances radiation-induced ERV expression, activates MDA5/MAVS signaling, and upregulates type I interferons, enhancing antitumor immunity and radiosensitization.","method":"Setdb1 genetic deletion, RNA-seq, ERV expression analysis, MDA5/MAVS pathway assay, in vivo radiotherapy mouse model","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with pathway-specific readouts (MDA5/MAVS), in vivo validation, mechanistic pathway established","pmids":["35648422"],"is_preprint":false},{"year":2022,"finding":"ATF7IP interacts with SETDB1 to regulate hematopoiesis in zebrafish through Setdb1-mediated H3K9me3 modification and chromatin remodeling. Interaction of ATF7IP and SETDB1 triggers H3K9me3 deposition at hematopoietic regulatory genes (cebpβ, cdkn1a), preventing premature myeloid differentiation and maintaining HSPC expansion.","method":"Zebrafish Atf7ip/Setdb1 mutants, H3K9me3 ChIP-seq, RNA-seq, retrotransposon assay","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 / Moderate — zebrafish genetic models with genome-wide ChIP-seq and pathway epistasis; specific target gene H3K9me3 validated","pmids":["36577070"],"is_preprint":false},{"year":2022,"finding":"H3K9me3 deposited by SETDB1 prevents aberrant CTCF binding at SINE B2 retrotransposon-enriched sites, independently of DNA methylation and H3K9me2. Loss of SETDB1 disrupts chromatin loops and local 3D interactions (but not overall TADs or subnuclear compartments), leading to transcriptional changes via altered cis-regulatory interactions.","method":"SETDB1 depletion in multiple mouse cell types, CTCF ChIP-seq, H3K9me3 ChIP-seq, Hi-C, ATAC-seq, DNA methylation analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide multi-omics in multiple cell types, epistasis with DNA methylation pathway, multiple orthogonal genome architecture methods","pmids":["38167730"],"is_preprint":false},{"year":2023,"finding":"SETDB1 methylates MCT1 (monocarboxylate transporter 1) at K473 in vitro and in vivo. This methylation inhibits the interaction between MCT1 and Tollip, blocking Tollip-mediated autophagic degradation of MCT1, thereby stabilizing MCT1 and enhancing the lactate shuttle in colorectal cancer.","method":"In vitro methyltransferase assay, Co-immunoprecipitation, site-directed mutagenesis (K473), autophagy assay","journal":"Advanced science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro methyltransferase assay on non-histone substrate with site-specific mutagenesis, Co-IP to define MCT1-Tollip interaction disruption; single lab","pmids":["37541664"],"is_preprint":false},{"year":2023,"finding":"SETDB1 interacts with and methylates ASK1 (apoptosis signal-regulating kinase 1) at lysine residues, and this methylation promotes ASK1 phosphorylation and activation of downstream JNK/p38 signaling in hepatic ischemia-reperfusion injury. SETDB1 inhibition reduces ASK1 phosphorylation and downstream pathway activation; overexpression of ASK1 rescues this effect.","method":"Co-immunoprecipitation, in vitro methylation assay, ChIP, hepatocyte hypoxia/reoxygenation model, in vivo HIRI mouse model, rescue by ASK1 overexpression","journal":"Research (Washington D.C.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and methylation assay, rescue experiment; single lab, mechanistic details partially characterized","pmids":["37915765"],"is_preprint":false},{"year":2023,"finding":"SETDB1 methylates CD147 at K71 (K71me2), and this modification promotes FOSB expression via enhanced p38 phosphorylation, leading to tumor cell apoptosis. SETDB1 was identified as the catalytic methyltransferase for this modification.","method":"Specific anti-CD147-K71me2 antibody generation, in vitro methyltransferase assay, site-directed mutagenesis (K71R), RNA-seq, p38 phosphorylation assay, in vivo xenograft","journal":"Genes & diseases","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro methyltransferase assay with mutagenesis, but single lab with limited mechanistic validation of the K71me2-p38 link","pmids":["37692516"],"is_preprint":false},{"year":2023,"finding":"SETDB1's Tudor domain (in a methyltransferase-independent manner) binds methylated RB (retinoblastoma protein) and protects CDK4/6-phosphorylated RB from TRIM28-mediated ubiquitination and proteasomal degradation. TRIM28 binds and promotes ubiquitination of CDK4/6-phosphorylated RB.","method":"Co-immunoprecipitation, ubiquitination assay, SETDB1 Tudor domain mutant (methyltransferase-dead), antisense oligonucleotide knockdown, xenograft model","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — methyltransferase-independent Tudor domain function established by catalytic mutant, Co-IP of TRIM28-RB complex, multiple biochemical and in vivo validation approaches","pmids":["36637424"],"is_preprint":false},{"year":2023,"finding":"ATF7IP2 is a meiosis-specific partner of SETDB1 (ortholog of ATF7IP). In ATF7IP2-null male mice, XY chromosomes lose obligatory crossovers, autosomal axis length increases and crossover number increases, meiotic DNA double-strand break formation/repair is affected, and spermatogenesis is blocked.","method":"ATF7IP2 KO mouse, Co-immunoprecipitation with SETDB1, cytological meiotic spread, ChIP for histone modifications","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP establishes SETDB1 partnership, KO phenotype defined, histone modification changes documented; single lab","pmids":["37542719"],"is_preprint":false},{"year":2024,"finding":"SETDB1 is required for adult muscle stem cell (MuSC) regeneration. SETDB1 represses ERVs in MuSCs; ERV derepression in Setdb1-null MuSCs activates the cGAS-STING DNA-sensing pathway, induces cytokine expression, causes aberrant immune cell infiltration (histiocytosis), and prevents MuSC amplification, abolishing muscle repair.","method":"MuSC-specific Setdb1 KO, multi-omics (ATAC-seq, RNA-seq, ChIP-seq), cGAS-STING pathway analysis, intravital imaging, in vivo muscle regeneration model","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO with multi-omics and pathway-specific validation; cGAS-STING mechanism established","pmids":["38848717"],"is_preprint":false},{"year":2019,"finding":"IRTKS recruits deubiquitinase OTUD4 to remove K48-linked polyubiquitin at K182/K1050 of SETDB1, blocking its proteasomal degradation, thereby increasing SETDB1 protein stability and H3K9me3 deposition. Enhanced SETDB1 activity suppresses CDH1 (E-cadherin) transcription via reduced chromatin accessibility, promoting EMT and tumor metastasis.","method":"Co-immunoprecipitation, ubiquitination assay, site-directed mutagenesis (K182/K1050), ATAC-seq, ChIP-seq","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, site-specific ubiquitination sites defined by mutagenesis, functional consequence in ATAC-seq/ChIP-seq; single lab","pmids":["37739210"],"is_preprint":false},{"year":2016,"finding":"T cell-specific deletion of ESET/SETDB1 impairs thymocyte development, particularly CD8 lineage cells, through ectopic expression of FcγRIIB in ESET-null thymocytes. FcγRIIB signaling inhibits TCR-induced ERK activation. A KMT1E-containing complex directly interacts with the FcγRIIb promoter; H3K9me3 at this promoter is dependent on Setdb1. Genetic depletion of FcγRIIB in ESET-null thymocytes partially rescues defective positive selection.","method":"T cell-specific conditional KO, genome-wide mRNA/H3K9me3 profiling, ChIP at FcγRIIb promoter, double KO epistasis (ESET–FcγRIIb)","journal":"Journal of immunology; Genes and immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double KO, direct ChIP at target promoter, two independent studies (Takikita et al. and Martin et al.) identifying same mechanism","pmids":["27511731","25569264"],"is_preprint":false},{"year":2008,"finding":"Monoallelic deletion of CBP leads to induction of ESET expression via elevated Ets-2 occupancy at the ESET promoter (CBP normally represses ESET transcription by limiting Ets-2 activity). Induced ESET increases H3K9 trimethylation and pericentric heterochromatin condensation in neurons.","method":"ESET promoter deletion/mutation analysis, luciferase reporter assay, ChIP (Ets-2 at ESET promoter), CBP siRNA, CBP+/- mouse model","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter mutational analysis, ChIP, and functional reporter assay establish transcriptional regulatory mechanism for ESET expression; single lab","pmids":["18319327"],"is_preprint":false},{"year":2022,"finding":"In C. elegans (MET-2, SETDB1 homolog), MET-2 has a noncatalytic function that contributes to gene repression independently of H3K9me. Catalytically deficient MET-2 still forms subnuclear foci and maintains silencing of a subset of genes by blocking acetylation on H3K9 and H3K27. Under heat stress, MET-2 foci disperse, coinciding with derepression. LIN-61 is a cofactor required for this noncatalytic function.","method":"Catalytically dead MET-2 mutant analysis in C. elegans, immunofluorescence, H3K9me and acetylation ChIP, gene expression analysis","journal":"Nature structural & molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — noncatalytic function proven by catalytic mutant in orthologous C. elegans system; chromatin acetylation blocking established","pmids":["35102319"],"is_preprint":false},{"year":2019,"finding":"In C. elegans, the unstructured cofactor LIN-65 (along with ARLE-14) binds MET-2 (SETDB1 homolog). Ablation of lin-65 mislocalizes and destabilizes MET-2, resulting in decreased H3K9me2, dispersion of heterochromatic foci, and derepression of MET-2 targets. LIN-65 and MET-2 also maintain perinuclear anchoring of genomic heterochromatin.","method":"Mass spectrometry (cofactor identification), RNAi/genetic ablation, immunofluorescence, H3K9me2 ChIP, genome-wide expression analysis","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS identification plus genetic ablation with multiple readouts; orthologous C. elegans system","pmids":["30737265"],"is_preprint":false},{"year":2022,"finding":"SETDB1 interacts with PELP1 (ER coregulator) in breast cancer cells, and PELP1 is required for SETDB1-mediated Akt methylation and phosphorylation. Knockdown of PELP1 abolishes SETDB1-mediated tamoxifen resistance and tumor progression in vivo.","method":"Yeast two-hybrid screen, co-immunoprecipitation, GST pulldown, in vitro methylation assay, xenograft model","journal":"Breast cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus GST pulldown plus Co-IP for interaction, in vitro methylation assay for functional consequence, in vivo rescue; single lab","pmids":["35395812"],"is_preprint":false},{"year":2013,"finding":"ESET/SETDB1 is required for ESET-mediated repression of Runx2 transcriptional activity in osteoblasts; co-transfection of ESET represses Runx2-mediated luciferase reporter, and siRNA knockdown activates it. ESET deletion severely impairs osteoblast differentiation and is required for Indian hedgehog expression in the growth plate.","method":"ESET mesenchyme-specific conditional KO, luciferase reporter (Runx2-mediated), siRNA knockdown","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo KO with defined differentiation phenotype, reporter assay demonstrating Runx2 repression; single lab","pmids":["24188826"],"is_preprint":false},{"year":2010,"finding":"Drosophila SETDB1 (dSETDB1) tri-methylates H3-K9, binds methylated CpA motifs, and recruits DNA methyltransferase Dnmt2 and HP1 (Su(var)205) to trigger DNA methylation and silencing of target genes and retrotransposons. dSETDB1 is involved in postembryonic DNA methylation of retrotransposons and the tumor suppressor Rb in imaginal discs.","method":"Drosophila cell culture, in vitro H3-K9 methyltransferase assay, DNA methylation assay, ChIP, RNAi knockdown","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro enzymatic assay plus ChIP and RNAi in Drosophila system; orthologous but distinct DNA methylation mechanism from mammals","pmids":["20498723"],"is_preprint":false}],"current_model":"SETDB1 is a euchromatic histone H3K9 methyltransferase (requiring its SET domain for catalytic activity) that deposits H3K9me2/3 to silence endogenous retroviruses/transposable elements, developmental genes, and select tissue-specific loci; it operates in complexes with KAP1/TRIM28, ATF7IP, KRAB-ZFPs, and OCT4, is recruited to chromatin partly via its tandem Tudor domain, regulated by ATF7IP-dependent nuclear retention and monoubiquitination, and also methylates non-histone substrates including AKT (K64), p53 (K370), UBF (K232/254), MCT1 (K473), ASK1, and CD147 (K71) to modulate their stability or activity in development and cancer."},"narrative":{"mechanistic_narrative":"SETDB1 (ESET/KMT1E) is a SET-domain histone H3 lysine 9 methyltransferase that deposits H3K9me2/3 to establish and maintain repressive chromatin across endogenous retroviruses, transposable elements, developmental regulators, and lineage-restricted loci, and is essential for peri-implantation development and ES cell survival [PMID:11791185, PMID:14993285, PMID:20164836]. Its core silencing activity is exerted within complexes nucleated by KAP1/TRIM28 and sequence-specific KRAB-zinc-finger proteins, which target SETDB1 to retroviral and transposon sequences for H3K9me3 deposition and HP1 binding in a DNA-methylation-independent manner [PMID:20164836, PMID:23293284, PMID:33953401]; SETDB1 also bridges to the de novo DNA methylation machinery (DNMT3A/3B) and other recruiters including OCT4, KDM5B, SMAD3, and AGO2 to silence developmental, lineage, and tissue-specific targets [PMID:16682412, PMID:19884257, PMID:19811652, PMID:25183519, PMID:29233829, PMID:34671158]. Loss of SETDB1 derepresses ERVs and transposons, which generates cytosolic nucleic acids that activate cGAS-STING and MDA5/MAVS sensing and a type I interferon response — a mechanism that drives antitumor immunity but also causes DNA damage and cell death in epithelia, muscle stem cells, and ground-state ES cells [PMID:34671158, PMID:31914391, PMID:32503845, PMID:33953401, PMID:35648422, PMID:38848717]. Beyond histone substrates, SETDB1 methylates non-histone proteins to control their stability and signaling, including p53 K370me2 (limiting MDM2-mediated degradation) [PMID:26471002], UBF (repressing rDNA transcription) [PMID:24234436], AKT K64 (enabling membrane recruitment and activation) [PMID:30692626, PMID:30692625], and MCT1 K473 (blocking autophagic degradation) [PMID:37541664]. SETDB1 silencing also organizes 3D genome architecture, with H3K9me3 at SINE/B2 and protocadherin-locus elements excluding aberrant CTCF binding to preserve chromatin loop topology [PMID:28671686, PMID:38167730]. SETDB1 abundance, nuclear retention, and activity are regulated by ATF7IP-dependent nuclear import coupled to ubiquitination and by monoubiquitination of the enzyme [PMID:31576654, PMID:31576653], and its tandem Tudor domain reads dual methyl/acetyl histone marks and, independently of catalysis, stabilizes phosphorylated RB against TRIM28-mediated degradation [PMID:33511756, PMID:36637424].","teleology":[{"year":2002,"claim":"Establishing SETDB1 as a bona fide enzyme answered what biochemical activity it carries: it is a SET-domain-dependent H3K9 methyltransferase that also physically partners with a sequence-specific transcription factor.","evidence":"In vitro HMT assay with SET-domain active-site mutagenesis plus GST pulldown/Co-IP with ERG","pmids":["11791185"],"confidence":"High","gaps":["Did not define genome-wide targets","Mechanism of chromatin recruitment unresolved"]},{"year":2004,"claim":"Genetic knockout established that SETDB1 is non-redundantly required for early embryogenesis and ES cell viability, placing its H3K9 methylation activity at the center of pluripotency maintenance.","evidence":"Mouse homozygous knockout with lacZ reporter and immunofluorescence localization to euchromatin","pmids":["14993285"],"confidence":"High","gaps":["Did not identify the silenced loci responsible for lethality","No catalytic-versus-structural requirement test"]},{"year":2006,"claim":"Linking SETDB1 to de novo DNA methyltransferases showed how H3K9 methylation is coordinated with DNA methylation at silenced promoters.","evidence":"Co-IP/GST pulldown with DNMT3A/3B (not DNMT1), Gal4-tethering reporter, and ChIP at endogenous CpG-methylated promoters","pmids":["16682412"],"confidence":"High","gaps":["Causal order of H3K9me and DNA methylation not resolved here","Generality across loci untested"]},{"year":2009,"claim":"Identifying OCT4 and the KRAB-ZFP/KAP1 axis as recruiters defined how SETDB1 is targeted to lineage genes and proviruses, and showed SETDB1 represses developmental/bivalent genes.","evidence":"Reciprocal Co-IP with SUMO-dependent OCT4 binding, ChIP-seq, shRNA and blastocyst injection","pmids":["19884257","19811652","19884255"],"confidence":"High","gaps":["How SUMO/SIM recognition integrates with catalytic targeting unclear","Distinction of direct vs indirect targets incomplete"]},{"year":2010,"claim":"Demonstrating KAP1/TRIM28-dependent, DNA-methylation-independent retroviral silencing established SETDB1 as the principal H3K9me3 writer for ERV/proviral repression in ES cells.","evidence":"Conditional KO/shRNA, retroviral silencing assays, ChIP, and epistasis in Dnmt triple-KO ES cells","pmids":["20164836"],"confidence":"High","gaps":["Specificity determinants distinguishing SETDB1 from other H3K9 KMTs not fully mapped"]},{"year":2011,"claim":"Comparing SETDB1- and DNMT-dependent derepression showed the two pathways silence largely non-overlapping ERV sets and that ERV derepression rewires host transcription via chimeric transcripts.","evidence":"Conditional KO with RNA-seq/ChIP-seq versus Dnmt1/3a/3b triple-KO mESCs","pmids":["21624812"],"confidence":"High","gaps":["Functional consequences of individual chimeric transcripts unexplored"]},{"year":2013,"claim":"Extending the KRAB-ZFP–KAP1–SETDB1 module to de novo DNA methylation and to non-histone substrate methylation (UBF) broadened SETDB1's mechanistic scope beyond histone silencing.","evidence":"ES cell ERV reporter with bisulfite/ChIP and KAP1 KO; separately in vitro UBF methylation with mutagenesis and AFM","pmids":["23293284","24234436"],"confidence":"High","gaps":["Whether the same enzyme pool serves histone and non-histone substrates unknown","Recruitment to rDNA not defined"]},{"year":2013,"claim":"Defining ATF7IP-dependent nuclear retention and ubiquitination established a key regulatory layer controlling where and how active SETDB1 is.","evidence":"Co-IP, deletion mapping of N-terminal NES region, leptomycin B, ubiquitination assays, nuclear fractionation","pmids":["31576654","23782009"],"confidence":"High","gaps":["Identity of the E3 ligase(s) for activating ubiquitination not established","Link between ubiquitination state and catalytic rate quantitative mechanism unclear"]},{"year":2014,"claim":"Mapping SETDB1 into additional silencing complexes (SIN3A/HDAC, EZH2/Polycomb, SMAD2/3) and pathways (XCI maintenance, agRNA silencing, metastasis suppression) showed the breadth of contexts that co-opt its H3K9me3 activity.","evidence":"RNAi/ChIP/Co-IP for AGO2 and SIN3-HDAC; siRNA epistasis for MBD1–ATF7IP–SETDB1 in XCI; in vivo metastasis with SMAD2/3 Co-IP","pmids":["25183519","25028596","25477335"],"confidence":"Medium","gaps":["Direct vs indirect partnerships not all reciprocally validated","Single-lab observations for several axes"]},{"year":2015,"claim":"Identifying p53 K370 dimethylation revealed SETDB1 as a regulator of tumor suppressor stability, connecting its catalytic activity to cancer signaling.","evidence":"Co-IP, in vitro methyltransferase assay, siRNA, MDM2-degradation assay","pmids":["26471002"],"confidence":"High","gaps":["In vivo significance of p53-K370me2 not addressed here"]},{"year":2016,"claim":"Catalytic-mutant rescue in oocytes proved enzymatic activity is required for SETDB1's developmental functions, and lineage-/tissue-specific KOs (thymocytes, macrophages) showed locus-specific repression underlies distinct cell-fate and immune phenotypes.","evidence":"Oocyte conditional catalytic-domain KO with WT vs catalytically dead rescue; T cell and macrophage conditional KOs with target-promoter ChIP and epistasis","pmids":["27070551","27317807","27511731","25569264","27349785"],"confidence":"High","gaps":["How distinct target sets are selected in different cell types unresolved"]},{"year":2017,"claim":"Demonstrating SETDB1 control of 3D genome topology at the protocadherin TAD and its recruitment by SMAD3 to repress SNAI1 expanded its role from sequence-level silencing to chromatin architecture and signaling-coupled gene control.","evidence":"Neuron-specific KO with Hi-C/ChIP-seq/bisulfite; Co-IP/ChIP/reporter for Smad3–SETDB1 at SNAI1","pmids":["28671686","29233829"],"confidence":"High","gaps":["Whether CTCF exclusion is a direct H3K9me3 effect or secondary not fully separated here"]},{"year":2018,"claim":"Placing SETDB1 downstream of the meiotic DNA damage response via TRIM28 explained how H3K9me3 accumulates on the sex chromosomes to drive meiotic silencing.","evidence":"Spermatocyte conditional KO with ChIP, immunofluorescence, and proteomic identification of TRIM28 bridge","pmids":["30393076"],"confidence":"High","gaps":["Molecular signal coupling DDR to TRIM28–SETDB1 recruitment not fully defined"]},{"year":2019,"claim":"A burst of studies established SETDB1's non-histone methylation of AKT (K64) driving its activation, refined ATF7IP/Wde-dependent nuclear retention and monoubiquitination control, and showed ERV derepression activates innate immunity and necroptosis/Dux-driven 2C states upon SETDB1 loss.","evidence":"In vitro methylation + knock-in mouse for AKT; Drosophila/mammalian ubiquitination and nuclear-retention assays; CRISPR KO with RNA-seq/ChIP-seq, KDM5B recruitment, and Dux epistasis","pmids":["30692626","30692625","31576654","31576653","34671158","31914391","31088968","30737147"],"confidence":"High","gaps":["Whether non-histone and histone activities are coordinately regulated unknown","Recruitment specificity to immune-proximal ERVs incompletely defined"]},{"year":2021,"claim":"In vivo CRISPR screens established SETDB1-TRIM28/HUSH/ATF7IP as a repressor of immunostimulatory transposons and antigens whose loss triggers cGAS-STING/interferon-mediated antitumor immunity, while structural work defined the tandem Tudor domain as a druggable reader of dual methyl/acetyl histone marks.","evidence":"In vivo CRISPR screens with ChIP-seq/RNA-seq and immune-checkpoint experiments; ITC and co-crystal structure of TTD inhibitor; meiotic KO cytology","pmids":["33953401","34848497","34462284","33511756","33406415"],"confidence":"High","gaps":["TTD reader function's contribution to silencing vs catalysis not fully separated","Therapeutic window of TTD inhibition untested in this corpus"]},{"year":2022,"claim":"Mechanistic studies tied SETDB1-deposited H3K9me3 to CTCF exclusion at SINE B2 elements controlling chromatin loops, and extended the ERV-derepression/interferon axis to radiotherapy sensitization and hematopoiesis.","evidence":"Multi-omics (CTCF/H3K9me3 ChIP-seq, Hi-C, ATAC-seq) with DNA-methylation epistasis; in vivo radiotherapy model; zebrafish ATF7IP/Setdb1 mutants","pmids":["38167730","35648422","36577070"],"confidence":"High","gaps":["Direct mechanism by which H3K9me3 blocks CTCF binding biochemically unresolved"]},{"year":2023,"claim":"New non-histone substrates (MCT1, ASK1, CD147) and a catalysis-independent Tudor function (RB stabilization) expanded SETDB1 into a regulator of metabolism, stress signaling, and the cell cycle beyond chromatin silencing.","evidence":"In vitro methylation with site-directed mutagenesis and Co-IP for MCT1/ASK1/CD147; catalytic-dead Tudor mutant and ubiquitination assays for RB-TRIM28; IRTKS/OTUD4 stability axis","pmids":["37541664","37915765","37692516","36637424","37739210","37542719"],"confidence":"Medium","gaps":["Several substrate findings are single-lab","Physiological stoichiometry and in vivo relevance of some non-histone methylation events untested"]},{"year":2024,"claim":"Tissue-specific KO confirmed that SETDB1-mediated ERV repression is required for adult stem-cell function, with derepression triggering cGAS-STING-driven inflammation that blocks regeneration.","evidence":"MuSC-specific KO with ATAC/RNA/ChIP-seq, cGAS-STING analysis, and in vivo regeneration model","pmids":["38848717"],"confidence":"High","gaps":["Whether interferon induction or DNA damage dominates the regenerative failure not fully dissected"]},{"year":null,"claim":"How SETDB1 partitions its activity between H3K9 methylation, non-histone substrate methylation, and catalysis-independent Tudor reader functions — and how recruitment selects among ERVs, developmental genes, and non-histone targets — remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model coupling cofactor binding to substrate choice","Determinants of locus selectivity among many KRAB-ZFP/cofactor inputs unknown","Structure-function relationship of catalytic vs Tudor activities in vivo not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,6,13,17,23,39]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[17,23,39,13]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[33]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[5,6,20]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,10,24]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[5,6,19,38]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,6,19,38]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[5,20,46]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,3,18,34]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[22,26,31,36,44]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[16,17,23,45]}],"complexes":["KAP1/TRIM28-SETDB1 complex","HUSH complex","ATF7IP-SETDB1 complex","SIN3-HDAC complex"],"partners":["TRIM28","ATF7IP","OCT4","DNMT3A","KDM5B","SMAD3","ERG","PELP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15047","full_name":"Histone-lysine N-methyltransferase SETDB1","aliases":["ERG-associated protein with SET domain","ESET","Histone H3-K9 methyltransferase 4","H3-K9-HMTase 4","Lysine N-methyltransferase 1E","SET domain bifurcated 1"],"length_aa":1291,"mass_kda":143.2,"function":"Histone methyltransferase that specifically trimethylates 'Lys-9' of histone H3 (H3K9me3) (PubMed:11959841, PubMed:12869583, PubMed:14536086, PubMed:27237050, PubMed:39096901). H3 'Lys-9' trimethylation represents a specific tag for epigenetic transcriptional repression by recruiting HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones (PubMed:11959841, PubMed:12869583, PubMed:14536086, PubMed:27237050, PubMed:39096901). Mainly functions in euchromatin regions, thereby playing a central role in the silencing of euchromatic genes (PubMed:12869583, PubMed:14536086, PubMed:27237050, PubMed:39096901). H3 'Lys-9' trimethylation is coordinated with DNA methylation (PubMed:12869583, PubMed:14536086, PubMed:27237050, PubMed:39096901). Forms a complex with MBD1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation (PubMed:14536086). Its activity is dependent on MBD1 and is heritably maintained through DNA replication by being recruited by CAF-1 (PubMed:14536086). SETDB1 is targeted to histone H3 by TRIM28/TIF1B, a factor recruited by KRAB zinc-finger proteins (PubMed:24623306). Required for HUSH-mediated heterochromatin formation and gene silencing (PubMed:27732843). Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells (PubMed:24623306). Required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) (PubMed:24623306). In ESCs, in collaboration with TRIM28, is also required for H3K9me3 and silencing of endogenous and introduced retroviruses in a DNA-methylation independent-pathway (PubMed:37938770). Associates at promoter regions of tumor suppressor genes (TSGs) leading to their gene silencing (PubMed:24623306). The SETDB1-TRIM28-ZNF274 complex may play a role in recruiting ATRX to the 3'-exons of zinc-finger coding genes with atypical chromatin signatures to establish or maintain/protect H3K9me3 at these transcriptionally active regions (PubMed:27029610). Also catalyzes mono- and dimethylation of 'Lys-9' of free histone H3 (H3K9me1 and H3K9me2) during translation in the cytoplasm, which is then transported to the nucleus and incorporated into nucleosomes (PubMed:26405197) Lacks all domains required for histone methyltransferase activity","subcellular_location":"Nucleus; Cytoplasm; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q15047/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/SETDB1","classification":"Common Essential","n_dependent_lines":662,"n_total_lines":1208,"dependency_fraction":0.5480132450331126},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ARL14EP","stoichiometry":10.0},{"gene":"CBX1","stoichiometry":0.2},{"gene":"NUMA1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/SETDB1","total_profiled":1310},"omim":[{"mim_id":"617566","title":"ZINC FINGER PROTEIN 568; ZNF568","url":"https://www.omim.org/entry/617566"},{"mim_id":"616661","title":"MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 2; MORC2","url":"https://www.omim.org/entry/616661"},{"mim_id":"616493","title":"TRANSCRIPTION ACTIVATION REPRESSOR; TASOR","url":"https://www.omim.org/entry/616493"},{"mim_id":"614349","title":"ZINC FINGER PROTEIN 638; ZNF638","url":"https://www.omim.org/entry/614349"},{"mim_id":"613645","title":"ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN 2; ATF7IP2","url":"https://www.omim.org/entry/613645"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SETDB1"},"hgnc":{"alias_symbol":["KG1T","KIAA0067","ESET","KMT1E","TDRD21"],"prev_symbol":[]},"alphafold":{"accession":"Q15047","domains":[{"cath_id":"-","chopping":"23-90","consensus_level":"medium","plddt":84.7034,"start":23,"end":90},{"cath_id":"2.30.30.140","chopping":"192-344","consensus_level":"high","plddt":93.0814,"start":192,"end":344},{"cath_id":"3.30.890","chopping":"581-658","consensus_level":"high","plddt":89.7151,"start":581,"end":658},{"cath_id":"2.170.270.10","chopping":"678-867_1204-1264","consensus_level":"high","plddt":90.498,"start":678,"end":1264}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15047","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15047-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15047-F1-predicted_aligned_error_v6.png","plddt_mean":65.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SETDB1","jax_strain_url":"https://www.jax.org/strain/search?query=SETDB1"},"sequence":{"accession":"Q15047","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15047.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15047/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15047"}},"corpus_meta":[{"pmid":"20164836","id":"PMC_20164836","title":"Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.","date":"2010","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/20164836","citation_count":649,"is_preprint":false},{"pmid":"21624812","id":"PMC_21624812","title":"DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs.","date":"2011","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/21624812","citation_count":427,"is_preprint":false},{"pmid":"14993285","id":"PMC_14993285","title":"Histone H3-K9 methyltransferase ESET is essential for early development.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14993285","citation_count":310,"is_preprint":false},{"pmid":"33953401","id":"PMC_33953401","title":"Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33953401","citation_count":299,"is_preprint":false},{"pmid":"19884255","id":"PMC_19884255","title":"SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state.","date":"2009","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/19884255","citation_count":282,"is_preprint":false},{"pmid":"16682412","id":"PMC_16682412","title":"The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16682412","citation_count":259,"is_preprint":false},{"pmid":"34671158","id":"PMC_34671158","title":"KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34671158","citation_count":222,"is_preprint":false},{"pmid":"11791185","id":"PMC_11791185","title":"Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11791185","citation_count":218,"is_preprint":false},{"pmid":"19884257","id":"PMC_19884257","title":"Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells.","date":"2009","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/19884257","citation_count":212,"is_preprint":false},{"pmid":"30692626","id":"PMC_30692626","title":"SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30692626","citation_count":158,"is_preprint":false},{"pmid":"23293284","id":"PMC_23293284","title":"De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23293284","citation_count":146,"is_preprint":false},{"pmid":"28671686","id":"PMC_28671686","title":"The methyltransferase SETDB1 regulates a large neuron-specific topological chromatin domain.","date":"2017","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28671686","citation_count":135,"is_preprint":false},{"pmid":"26471002","id":"PMC_26471002","title":"Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26471002","citation_count":133,"is_preprint":false},{"pmid":"30692625","id":"PMC_30692625","title":"AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions.","date":"2019","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30692625","citation_count":131,"is_preprint":false},{"pmid":"22991445","id":"PMC_22991445","title":"Essential roles of the histone methyltransferase ESET in the epigenetic control of neural progenitor cells during development.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22991445","citation_count":124,"is_preprint":false},{"pmid":"23770855","id":"PMC_23770855","title":"Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23770855","citation_count":111,"is_preprint":false},{"pmid":"19811652","id":"PMC_19811652","title":"ERG-associated protein with SET domain (ESET)-Oct4 interaction regulates pluripotency and represses the trophectoderm lineage.","date":"2009","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/19811652","citation_count":103,"is_preprint":false},{"pmid":"36436682","id":"PMC_36436682","title":"CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer.","date":"2022","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/36436682","citation_count":102,"is_preprint":false},{"pmid":"20505083","id":"PMC_20505083","title":"Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20505083","citation_count":97,"is_preprint":false},{"pmid":"32486217","id":"PMC_32486217","title":"SETDB1-Mediated Silencing of Retroelements.","date":"2020","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/32486217","citation_count":88,"is_preprint":false},{"pmid":"30737147","id":"PMC_30737147","title":"The Histone Methyltransferase SETDB1 Controls T Helper Cell Lineage Integrity by Repressing Endogenous Retroviruses.","date":"2019","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/30737147","citation_count":84,"is_preprint":false},{"pmid":"33115801","id":"PMC_33115801","title":"Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33115801","citation_count":81,"is_preprint":false},{"pmid":"31914391","id":"PMC_31914391","title":"SETDB1-Mediated Cell Fate Transition between 2C-Like and Pluripotent States.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31914391","citation_count":79,"is_preprint":false},{"pmid":"20014010","id":"PMC_20014010","title":"KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation.","date":"2010","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/20014010","citation_count":76,"is_preprint":false},{"pmid":"27070551","id":"PMC_27070551","title":"Maternal Setdb1 Is Required for Meiotic Progression and Preimplantation Development in Mouse.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27070551","citation_count":76,"is_preprint":false},{"pmid":"32503845","id":"PMC_32503845","title":"SETDB1 is required for intestinal epithelial differentiation and the prevention of intestinal inflammation.","date":"2020","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/32503845","citation_count":74,"is_preprint":false},{"pmid":"30393076","id":"PMC_30393076","title":"SETDB1 Links the Meiotic DNA Damage Response to Sex Chromosome Silencing in Mice.","date":"2018","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/30393076","citation_count":73,"is_preprint":false},{"pmid":"27317807","id":"PMC_27317807","title":"The methyltransferase Setdb1 is essential for meiosis and mitosis in mouse oocytes and early embryos.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27317807","citation_count":72,"is_preprint":false},{"pmid":"30850015","id":"PMC_30850015","title":"Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.","date":"2019","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/30850015","citation_count":71,"is_preprint":false},{"pmid":"25028596","id":"PMC_25028596","title":"The Mbd1-Atf7ip-Setdb1 pathway contributes to the maintenance of X chromosome inactivation.","date":"2014","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/25028596","citation_count":71,"is_preprint":false},{"pmid":"34094655","id":"PMC_34094655","title":"SETDB1 in cancer: overexpression and its therapeutic implications.","date":"2021","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34094655","citation_count":69,"is_preprint":false},{"pmid":"25404354","id":"PMC_25404354","title":"SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway.","date":"2014","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25404354","citation_count":67,"is_preprint":false},{"pmid":"31576654","id":"PMC_31576654","title":"ATF7IP regulates SETDB1 nuclear localization and increases its ubiquitination.","date":"2019","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/31576654","citation_count":66,"is_preprint":false},{"pmid":"29233829","id":"PMC_29233829","title":"Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial-mesenchymal transition.","date":"2017","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/29233829","citation_count":65,"is_preprint":false},{"pmid":"34848497","id":"PMC_34848497","title":"The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.","date":"2021","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/34848497","citation_count":64,"is_preprint":false},{"pmid":"25477335","id":"PMC_25477335","title":"H3K9 histone methyltransferase, KMT1E/SETDB1, cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/25477335","citation_count":56,"is_preprint":false},{"pmid":"28076698","id":"PMC_28076698","title":"Emerging role of SETDB1 as a therapeutic target.","date":"2017","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/28076698","citation_count":55,"is_preprint":false},{"pmid":"34801472","id":"PMC_34801472","title":"Histone methyltransferase SETDB1 inhibits TGF-β-induced epithelial-mesenchymal transition in pulmonary fibrosis by regulating SNAI1 expression and the ferroptosis signaling pathway.","date":"2021","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/34801472","citation_count":55,"is_preprint":false},{"pmid":"30545440","id":"PMC_30545440","title":"SETDB1 regulates SMAD7 expression for breast cancer metastasis.","date":"2019","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/30545440","citation_count":52,"is_preprint":false},{"pmid":"37541664","id":"PMC_37541664","title":"SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37541664","citation_count":51,"is_preprint":false},{"pmid":"38520019","id":"PMC_38520019","title":"LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling.","date":"2024","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38520019","citation_count":49,"is_preprint":false},{"pmid":"31131878","id":"PMC_31131878","title":"Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.","date":"2019","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31131878","citation_count":48,"is_preprint":false},{"pmid":"32393761","id":"PMC_32393761","title":"SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32393761","citation_count":47,"is_preprint":false},{"pmid":"30309377","id":"PMC_30309377","title":"Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation.","date":"2018","source":"Biological research","url":"https://pubmed.ncbi.nlm.nih.gov/30309377","citation_count":47,"is_preprint":false},{"pmid":"34440561","id":"PMC_34440561","title":"Structure, Activity and Function of the SETDB1 Protein Methyltransferase.","date":"2021","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34440561","citation_count":44,"is_preprint":false},{"pmid":"24556744","id":"PMC_24556744","title":"Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion.","date":"2014","source":"Asian journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/24556744","citation_count":44,"is_preprint":false},{"pmid":"31858687","id":"PMC_31858687","title":"Hdac3, Setdb1, and Kap1 mark H3K9me3/H3K14ac bivalent regions in young and aged liver.","date":"2019","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/31858687","citation_count":43,"is_preprint":false},{"pmid":"31306481","id":"PMC_31306481","title":"Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.","date":"2020","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31306481","citation_count":42,"is_preprint":false},{"pmid":"25183519","id":"PMC_25183519","title":"AGO2 and SETDB1 cooperate in promoter-targeted transcriptional silencing of the androgen receptor gene.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25183519","citation_count":42,"is_preprint":false},{"pmid":"33511756","id":"PMC_33511756","title":"Structure-Guided Discovery of a Potent and Selective Cell-Active Inhibitor of SETDB1 Tudor Domain.","date":"2021","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/33511756","citation_count":42,"is_preprint":false},{"pmid":"27511731","id":"PMC_27511731","title":"A Histone Methyltransferase ESET Is Critical for T Cell Development.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27511731","citation_count":41,"is_preprint":false},{"pmid":"27349785","id":"PMC_27349785","title":"The H3K9 methyltransferase Setdb1 regulates TLR4-mediated inflammatory responses in macrophages.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27349785","citation_count":41,"is_preprint":false},{"pmid":"29739365","id":"PMC_29739365","title":"Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29739365","citation_count":40,"is_preprint":false},{"pmid":"24188826","id":"PMC_24188826","title":"ESET histone methyltransferase regulates osteoblastic differentiation of mesenchymal stem cells during postnatal bone development.","date":"2013","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/24188826","citation_count":38,"is_preprint":false},{"pmid":"23652029","id":"PMC_23652029","title":"ESET histone methyltransferase is essential to hypertrophic differentiation of growth plate chondrocytes and formation of epiphyseal plates.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23652029","citation_count":38,"is_preprint":false},{"pmid":"23782009","id":"PMC_23782009","title":"Regulated nuclear entry of over-expressed Setdb1.","date":"2013","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/23782009","citation_count":38,"is_preprint":false},{"pmid":"31576653","id":"PMC_31576653","title":"Essential roles of Windei and nuclear monoubiquitination of Eggless/SETDB1 in transposon silencing.","date":"2019","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/31576653","citation_count":38,"is_preprint":false},{"pmid":"32360551","id":"PMC_32360551","title":"SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.","date":"2020","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/32360551","citation_count":37,"is_preprint":false},{"pmid":"18319327","id":"PMC_18319327","title":"Monoallele deletion of CBP leads to pericentromeric heterochromatin condensation through ESET expression and histone H3 (K9) methylation.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18319327","citation_count":37,"is_preprint":false},{"pmid":"34462284","id":"PMC_34462284","title":"Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity.","date":"2021","source":"Cancer immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/34462284","citation_count":37,"is_preprint":false},{"pmid":"24763053","id":"PMC_24763053","title":"The histone methyltransferase ESET is required for the survival of spermatogonial stem/progenitor cells in mice.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24763053","citation_count":36,"is_preprint":false},{"pmid":"29926931","id":"PMC_29926931","title":"The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis.","date":"2018","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29926931","citation_count":36,"is_preprint":false},{"pmid":"35648422","id":"PMC_35648422","title":"SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy.","date":"2022","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35648422","citation_count":35,"is_preprint":false},{"pmid":"14522075","id":"PMC_14522075","title":"Genomic structure and expression of the mouse ESET gene encoding an ERG-associated histone methyltransferase with a SET domain.","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/14522075","citation_count":34,"is_preprint":false},{"pmid":"32637583","id":"PMC_32637583","title":"Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma.","date":"2020","source":"Molecular therapy oncolytics","url":"https://pubmed.ncbi.nlm.nih.gov/32637583","citation_count":34,"is_preprint":false},{"pmid":"33044755","id":"PMC_33044755","title":"SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.","date":"2020","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33044755","citation_count":33,"is_preprint":false},{"pmid":"33054052","id":"PMC_33054052","title":"SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.","date":"2020","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/33054052","citation_count":32,"is_preprint":false},{"pmid":"32473242","id":"PMC_32473242","title":"Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/32473242","citation_count":31,"is_preprint":false},{"pmid":"33279625","id":"PMC_33279625","title":"Histone lysine methyltransferase SETDB1 as a novel target for central nervous system diseases.","date":"2020","source":"Progress in neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/33279625","citation_count":30,"is_preprint":false},{"pmid":"31088968","id":"PMC_31088968","title":"EHMT2 and SETDB1 protect the maternal pronucleus from 5mC oxidation.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31088968","citation_count":29,"is_preprint":false},{"pmid":"30737265","id":"PMC_30737265","title":"Heterochromatic foci and transcriptional repression by an unstructured MET-2/SETDB1 co-factor LIN-65.","date":"2019","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/30737265","citation_count":28,"is_preprint":false},{"pmid":"36637424","id":"PMC_36637424","title":"SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors.","date":"2023","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/36637424","citation_count":27,"is_preprint":false},{"pmid":"36580757","id":"PMC_36580757","title":"NF-κB p65 and SETDB1 expedite lipopolysaccharide-induced intestinal inflammation in mice by inducing IRF7/NLR-dependent macrophage M1 polarization.","date":"2022","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36580757","citation_count":27,"is_preprint":false},{"pmid":"38167730","id":"PMC_38167730","title":"Cell-type differential targeting of SETDB1 prevents aberrant CTCF binding, chromatin looping, and cis-regulatory interactions.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38167730","citation_count":26,"is_preprint":false},{"pmid":"33406415","id":"PMC_33406415","title":"The Essential Function of SETDB1 in Homologous Chromosome Pairing and Synapsis during Meiosis.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/33406415","citation_count":26,"is_preprint":false},{"pmid":"26949019","id":"PMC_26949019","title":"SETDB1 mediated FosB expression increases the cell proliferation rate during anticancer drug therapy.","date":"2016","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/26949019","citation_count":26,"is_preprint":false},{"pmid":"36577070","id":"PMC_36577070","title":"Atf7ip and Setdb1 interaction orchestrates the hematopoietic stem and progenitor cell state with diverse lineage differentiation.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36577070","citation_count":24,"is_preprint":false},{"pmid":"35395812","id":"PMC_35395812","title":"SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance.","date":"2022","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/35395812","citation_count":24,"is_preprint":false},{"pmid":"38823098","id":"PMC_38823098","title":"Necroptosis contributes to the intestinal toxicity of deoxynivalenol and is mediated by methyltransferase SETDB1.","date":"2024","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/38823098","citation_count":22,"is_preprint":false},{"pmid":"20498723","id":"PMC_20498723","title":"SETDB1 is involved in postembryonic DNA methylation and gene silencing in Drosophila.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20498723","citation_count":21,"is_preprint":false},{"pmid":"30054425","id":"PMC_30054425","title":"A regulatory circuitry comprising TP53, miR-29 family, and SETDB1 in non-small cell lung cancer.","date":"2018","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/30054425","citation_count":21,"is_preprint":false},{"pmid":"30403691","id":"PMC_30403691","title":"DNMTs and SETDB1 function as co-repressors in MAX-mediated repression of germ cell-related genes in mouse embryonic stem cells.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30403691","citation_count":21,"is_preprint":false},{"pmid":"30446626","id":"PMC_30446626","title":"SETDB1 is essential for mouse primordial germ cell fate determination by ensuring BMP signaling.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30446626","citation_count":20,"is_preprint":false},{"pmid":"37692516","id":"PMC_37692516","title":"SETDB1-mediated CD147-K71 di-methylation promotes cell apoptosis in non-small cell lung cancer.","date":"2023","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37692516","citation_count":19,"is_preprint":false},{"pmid":"24056368","id":"PMC_24056368","title":"Mesenchyme-specific knockout of ESET histone methyltransferase causes ectopic hypertrophy and terminal differentiation of articular chondrocytes.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24056368","citation_count":19,"is_preprint":false},{"pmid":"24234436","id":"PMC_24234436","title":"ESET methylates UBF at K232/254 and regulates nucleolar heterochromatin plasticity and rDNA transcription.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24234436","citation_count":18,"is_preprint":false},{"pmid":"31398867","id":"PMC_31398867","title":"Expression of the Major and Pro-Oncogenic H3K9 Lysine Methyltransferase SETDB1 in Non-Small Cell Lung Cancer.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31398867","citation_count":18,"is_preprint":false},{"pmid":"35445296","id":"PMC_35445296","title":"Expression of the histone lysine methyltransferases SETD1B, SETDB1, SETD2, and CFP1 exhibits significant changes in the oocytes and granulosa cells of aged mouse ovaries.","date":"2022","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35445296","citation_count":18,"is_preprint":false},{"pmid":"38057834","id":"PMC_38057834","title":"The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease.","date":"2023","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/38057834","citation_count":17,"is_preprint":false},{"pmid":"28913972","id":"PMC_28913972","title":"Significance of histone methyltransferase SETDB1 expression in colon adenocarcinoma.","date":"2017","source":"APMIS : acta pathologica, microbiologica, et immunologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/28913972","citation_count":17,"is_preprint":false},{"pmid":"35102319","id":"PMC_35102319","title":"SETDB1-like MET-2 promotes transcriptional silencing and development independently of its H3K9me-associated catalytic activity.","date":"2022","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35102319","citation_count":17,"is_preprint":false},{"pmid":"37542719","id":"PMC_37542719","title":"ATF7IP2, a meiosis-specific partner of SETDB1, is required for proper chromosome remodeling and crossover formation during spermatogenesis.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37542719","citation_count":15,"is_preprint":false},{"pmid":"37661095","id":"PMC_37661095","title":"Hyperglycaemia aggravates periodontal inflamm-aging by promoting SETDB1-mediated LINE-1 de-repression in macrophages.","date":"2023","source":"Journal of clinical periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/37661095","citation_count":15,"is_preprint":false},{"pmid":"20869373","id":"PMC_20869373","title":"Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.","date":"2010","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20869373","citation_count":15,"is_preprint":false},{"pmid":"35864175","id":"PMC_35864175","title":"EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35864175","citation_count":15,"is_preprint":false},{"pmid":"38848717","id":"PMC_38848717","title":"Setdb1 protects genome integrity in murine muscle stem cells to allow for regenerative myogenesis and inflammation.","date":"2024","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/38848717","citation_count":14,"is_preprint":false},{"pmid":"35682642","id":"PMC_35682642","title":"Enhanced Expression of Human Endogenous Retroviruses, TRIM28 and SETDB1 in Autism Spectrum Disorder.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35682642","citation_count":14,"is_preprint":false},{"pmid":"37739210","id":"PMC_37739210","title":"Cooperation between IRTKS and deubiquitinase OTUD4 enhances the SETDB1-mediated H3K9 trimethylation that promotes tumor metastasis via suppressing E-cadherin expression.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37739210","citation_count":14,"is_preprint":false},{"pmid":"37915765","id":"PMC_37915765","title":"Hepatocellular SETDB1 Regulates Hepatic Ischemia-Reperfusion Injury through Targeting Lysine Methylation of ASK1 Signal.","date":"2023","source":"Research (Washington, D.C.)","url":"https://pubmed.ncbi.nlm.nih.gov/37915765","citation_count":14,"is_preprint":false},{"pmid":"25569264","id":"PMC_25569264","title":"KMT1E-mediated chromatin modifications at the FcγRIIb promoter regulate thymocyte development.","date":"2015","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25569264","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50530,"output_tokens":13551,"usd":0.177427,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":25312,"output_tokens":6280,"usd":0.14178,"stage2_stop_reason":"end_turn"},"total_usd":0.319207,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"SETDB1/ESET is a histone H3-specific methyltransferase that catalyzes methylation of histone H3 at lysine 9; mutations within the SET domain abolish this activity. ESET interacts directly with the ERG transcription factor, demonstrated by GST pulldown, co-immunoprecipitation, and association of endogenous SETDB1 with ERG.\",\n      \"method\": \"In vitro histone methyltransferase assay, GST pulldown, co-immunoprecipitation, active-site mutagenesis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — enzymatic activity confirmed in vitro with mutagenesis, protein interaction confirmed by multiple orthogonal methods\",\n      \"pmids\": [\"11791185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"ESET/SETDB1 is essential for peri-implantation development and ES cell survival in mice; homozygous deletion results in lethality between 3.5–5.5 dpc and failure to establish ES cell lines. ESET localizes mainly in euchromatin and catalyzes H3-K9 methylation.\",\n      \"method\": \"Mouse knockout, lacZ reporter knock-in, immunofluorescence localization\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complete genetic knockout with defined developmental phenotype, replicated observations across multiple embryo/ES cell analyses\",\n      \"pmids\": [\"14993285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SETDB1 directly interacts with de novo DNA methyltransferases DNMT3A (through its N-terminus binding the plant homeodomain of DNMT3A) and DNMT3B, but not maintenance methyltransferase DNMT1. Co-expression of SETDB1 and DNMT3A is required for repression of reporter genes. Both proteins co-occupy CpG-methylated promoters of endogenous genes (p53BP2 in HeLa, RASSF1A in MDA-MB-231).\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro), GST pulldown, Gal4-tethering reporter assay, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct physical interaction confirmed by in vitro and in vivo methods, functional consequence shown in reporter assay, endogenous loci validated by ChIP\",\n      \"pmids\": [\"16682412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SETDB1/Eset interacts with Oct4 via a SUMO-interacting motif (SIM) in Oct4, and this complex deposits H3K9me3 at trophoblast-associated gene promoters (Cdx2, Tcfap2a) to repress them, restricting trophoblast lineage potential of ES cells. ESET is SUMOylated and localizes to PML nuclear bodies in ES cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, shRNA knockdown, single-cell PCR, blastocyst injection\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, ChIP-seq, functional rescue, in vivo lineage tracing; independently corroborated by Yeap et al. 2009\",\n      \"pmids\": [\"19884257\", \"19811652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SUMOylated ESET interacts with Oct4 through Oct4's SUMO-interacting motif (SIM) to repress Cdx2 via H3K9me3. Loss of either ESET or Oct4 causes similar ES cell differentiation into trophectoderm and failure of ICM development.\",\n      \"method\": \"Co-immunoprecipitation, SUMOylation assay, ChIP, shRNA knockdown, immunofluorescence\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — interaction confirmed by Co-IP with SIM mutant, mechanistic link to H3K9me3 deposition at Cdx2 by ChIP, replicated across two independent studies\",\n      \"pmids\": [\"19811652\", \"19884257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SetDB1 occupies and represses genes encoding developmental regulators in ES cells, depositing H3K9me3. SetDB1-occupied genes are a subset of 'bivalent' genes marked by both H3K4me3 and H3K27me3, and are co-repressed by Polycomb group proteins and SetDB1.\",\n      \"method\": \"shRNA screen, ChIP-seq\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq with functional shRNA loss-of-function in ES cells, multiple lines of evidence in single study\",\n      \"pmids\": [\"19884255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ESET/SETDB1 and KAP1/TRIM28 are required for H3K9me3 deposition and silencing of endogenous and introduced retroviruses specifically in mouse ES cells, in a DNA-methylation-independent manner. ESET enzymatic activity is crucial for HP1 binding and proviral silencing; H4K20 methyltransferases Suv420h1/h2 are dispensable. In Dnmt triple-KO ES cells, ESET and KAP1 binding and H3K9me3 are maintained.\",\n      \"method\": \"Conditional knockout/shRNA, ChIP, retroviral silencing assay, Dnmt triple-knockout ES cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with defined molecular and functional readouts, epistasis experiments in Dnmt-null background, replicated across multiple retroviral reporters\",\n      \"pmids\": [\"20164836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Setdb1 controls global H3K9me2 levels in oocytes; transgenic overexpression of Setdb1 in forebrain neurons represses the NMDA receptor subunit NR2B/Grin2b gene via H3K9me3 deposition at a site 30 kb downstream of the TSS, mediated by chromatin loop formation. This results in altered NMDA receptor subunit composition and antidepressant-like behavior.\",\n      \"method\": \"Transgenic overexpression, ChIP-chip, chromatin conformation capture (3C), electrophysiology, behavioral assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-chip, 3C loop identification, electrophysiological validation, behavioral phenotyping in single study with multiple orthogonal methods\",\n      \"pmids\": [\"20505083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SETDB1 deletion in mESCs derepresses a distinct set of ERVs (with concomitant loss of H3K9me3) that is largely non-overlapping with genes derepressed by DNA methyltransferase deletion. ~15% of upregulated genes are induced by derepression of promoter-proximal ERVs, half as chimeric transcripts initiating within ERVs and splicing to downstream exons.\",\n      \"method\": \"Setdb1 conditional knockout, RNA-seq, ChIP-seq, comparison with Dnmt1/3a/3b triple-KO mESCs\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide sequencing with genetic KO and direct comparison to DNA methylation pathway, multiple independent analyses\",\n      \"pmids\": [\"21624812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"KRAB-ZFPs, KAP1, and ESET/SETDB1 are required for de novo DNA methylation of introduced ERV sequences in ES cells. ERV sequence-recognizing KRAB-ZFPs recruit KAP1 and ESET to direct de novo methylation that is subsequently maintained in vivo throughout embryogenesis. KAP1 knockout in early embryos affects ERV DNA methylation.\",\n      \"method\": \"ES cell reporter assay with introduced ERV sequences, conditional KAP1 knockout, bisulfite sequencing, ChIP\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional assay with introduced sequences, genetic knockouts, in vivo validation, multiple epigenetic readouts\",\n      \"pmids\": [\"23293284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ATF7IP (MCAF1) interacts with SETDB1 and promotes SETDB1 nuclear retention by binding its N-terminal region (which harbors nuclear export signals), and increases ubiquitination of SETDB1 to enhance its enzymatic activity.\",\n      \"method\": \"Co-immunoprecipitation, deletion mapping, leptomycin B treatment, ubiquitination assay, nuclear fractionation\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic dissection of nuclear localization via NES binding and ubiquitination using multiple biochemical methods in single focused study (published 2019, listed under 2013 PMID)\",\n      \"pmids\": [\"31576654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SETDB1 nuclear localization is regulated by its N-terminal region, which contains nuclear export signal motifs. The N-terminal region also contains a SUMO-interaction motif (SIM) required for association with PML nuclear bodies; SIM mutation causes disaggregation of PML-NB structure.\",\n      \"method\": \"GFP-fusion overexpression, leptomycin B treatment, deletion constructs, SIM mutagenesis, fluorescence microscopy\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, single study; localization mechanism characterized with deletion/mutant constructs but functional consequences limited to overexpressed protein behavior\",\n      \"pmids\": [\"23782009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ESET/SETDB1 associates with HDAC4 to bind and inhibit the activity of Runx2, a hypertrophy-promoting transcription factor; repression is dependent on ESET H3-K9 methyltransferase activity and its associated histone deacetylase activity. Conditional deletion of ESET SET domain in mesenchymal cells accelerates chondrocyte hypertrophy.\",\n      \"method\": \"Conditional knockout mice, co-expression/co-immunoprecipitation, luciferase reporter with Runx2, ChIP\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo KO phenotype, Co-IP, reporter assay with catalytic mutant, multiple orthogonal methods\",\n      \"pmids\": [\"23652029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ESET/SETDB1 methylates UBF (upstream binding factor) at K232 and K254, leading to nucleolar chromatin condensation and decreased rDNA transcriptional activity. Mutations K232/254A and K232/254R in UBF restore rDNA transcription. ESET-ΔSET mutant and ESET shRNA knockdown reduce UBF trimethylation and restore rDNA transcription.\",\n      \"method\": \"Co-immunoprecipitation, in vitro methyltransferase assay, UBF mutagenesis, shRNA knockdown, atomic force microscopy, luciferase reporter\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro methyltransferase assay on non-histone substrate with mutagenesis, structural (AFM) confirmation, functional reporter readout\",\n      \"pmids\": [\"24234436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SETDB1 cooperates with AGO2 in agRNA-induced transcriptional gene silencing of the androgen receptor (AR) gene promoter. AGO2 is recruited first to the AR promoter, followed by SETDB1; knockdown of either blocks silencing. SETDB1 interacts with SIN3A and HDAC1/2 (components of SIN3-HDAC complex) and with EZH2, and its presence is associated with H3K9me3 enrichment at the targeted promoter.\",\n      \"method\": \"RNAi knockdown, ChIP, co-immunoprecipitation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and Co-IP with ordered recruitment analysis, functional knockdown, multiple interactors identified\",\n      \"pmids\": [\"25183519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The MBD1–ATF7IP–SETDB1 pathway contributes to X chromosome inactivation maintenance in somatic cells. Knockdown of ATF7IP, MBD1, or SETDB1 (but not other H3K9 methyltransferases) activates silenced Xi-linked reporter genes. ATF7IP links DNA methylation on Xi to SETDB1-mediated H3K9me3 via MBD1 interaction.\",\n      \"method\": \"siRNA knockdown, Xi-linked reporter gene reactivation assay, co-immunoprecipitation\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional knockdown with specific pathway epistasis using multiple proteins, reporter assay, Co-IP; single lab\",\n      \"pmids\": [\"25028596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"KMT1E/SETDB1 cooperates with the SMAD2/3 complex to repress ANXA2 and suppress lung cancer metastasis. Restoring KMT1E expression suppresses filopodia formation, migration, and invasion; loss promotes metastasis in vivo.\",\n      \"method\": \"Re-expression and knockdown of KMT1E, migration/invasion assays, in vivo metastasis model, co-immunoprecipitation (SMAD2/3 interaction)\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo metastasis model plus mechanistic interaction with SMAD2/3 complex, single lab\",\n      \"pmids\": [\"25477335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SETDB1 forms a complex with p53 and catalyzes di-methylation of p53 at K370. SETDB1 attenuation reduces p53-K370me2 levels, leading to increased MDM2-mediated degradation of p53.\",\n      \"method\": \"Co-immunoprecipitation, in vitro methyltransferase assay, ChIP, siRNA knockdown, MDM2 degradation assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro methyltransferase assay on non-histone substrate, Co-IP, functional consequence (MDM2-mediated degradation) established, multiple biochemical methods\",\n      \"pmids\": [\"26471002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Setdb1 controls global H3K9me2 levels in oocytes (with EHMT2 controlling H3K9me3 in the maternal pronucleus). Conditional deletion of Setdb1 catalytic domain in oocytes causes meiotic arrest, with meiotic resumption delayed and upregulation of Cdc14b (a phosphatase that inhibits meiotic progression). Catalytic activity of Setdb1 is required for meiotic progression, demonstrated by rescue with wild-type but not catalytically inactive Setdb1.\",\n      \"method\": \"Conditional knockout, rescue experiment with catalytic mutant, immunofluorescence, microarray\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — catalytic requirement proven by rescue with inactive mutant; two independent KO studies (Kim et al., Eymery et al.) converge on meiotic arrest phenotype\",\n      \"pmids\": [\"27070551\", \"27317807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SETDB1 neuronal ablation causes locus-specific disintegration of a 1.2-Mb topologically associated domain at the clustered protocadherin locus (TADcPcdh). Loss of SETDB1 leads to DNA hypomethylation, abnormal accumulation of CTCF at cryptic binding sites, histone hyperacetylation, and upregulated cPcdh expression. SETDB1-dependent chromatin loops bypass 0.2–1 Mb of linear genome from TADcPcdh fringes to cis-regulatory sequences. A SETDB1 repressor complex involving KRAB zinc finger proteins prevents excess CTCF binding.\",\n      \"method\": \"Neuron-specific Setdb1 conditional KO, Hi-C/chromatin conformation capture, ChIP-seq, bisulfite sequencing, single-cell expression analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with genome-wide 3D chromatin analysis, ChIP-seq, multiple orthogonal methods demonstrating CTCF exclusion mechanism\",\n      \"pmids\": [\"28671686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SETDB1 is recruited by Smad3 to repress transcription of SNAI1 (Snail1) via H3K9 methylation at the SNAI1 gene, counteracting H3K9 acetylation imposed by activated Smad3/4 complexes during TGF-β-induced EMT. TGF-β induces downregulation of SETDB1 to relieve this repression.\",\n      \"method\": \"Co-immunoprecipitation (Smad3-SETDB1), ChIP, reporter assay, overexpression/knockdown\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ChIP demonstrate direct recruitment of SETDB1 by Smad3 to SNAI1 locus with H3K9me3 deposition, multiple orthogonal methods\",\n      \"pmids\": [\"29233829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SETDB1 links the meiotic DNA damage response (DDR) to sex chromosome silencing in male mice. TRIM28 connects DDR proteins to SETDB1, which deposits H3K9me3 on the X chromosome at the onset of meiotic silencing. Without Setdb1, H3K9me3 fails to accumulate on the X chromosome despite DDR protein loading, causing failure of sex chromosome remodeling and silencing, and germ cell apoptosis.\",\n      \"method\": \"Setdb1 conditional KO in spermatocytes, ChIP, immunofluorescence, proteomic identification of TRIM28 as bridge factor\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with ordered epistasis placing SETDB1 downstream of DDR and TRIM28, ChIP validates H3K9me3 loss, multiple independent readouts\",\n      \"pmids\": [\"30393076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"KDM5B recruits SETDB1 to repress endogenous retroelements (e.g., MMVL30) in a demethylase-independent manner. Derepression of these retroelements upon KDM5B/SETDB1 loss activates cytosolic RNA- and DNA-sensing pathways and type-I interferon response, leading to tumor rejection.\",\n      \"method\": \"CRISPR KO, ChIP, RNA-seq, immunostimulatory pathway analysis, in vivo tumor rejection assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KOs in vivo, ChIP demonstrating SETDB1 recruitment by KDM5B, multiple mechanistic readouts including interferon pathway activation\",\n      \"pmids\": [\"34671158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SETDB1 methylates Akt at K64 (referred to as K64 in one paper, K64-equivalent in context; the two papers identify the same residue as critical). This methylation is required for cell membrane recruitment, phosphorylation, and activation of Akt following growth factor stimulation. JMJD2A acts as an adaptor recognizing Akt K64 methylation to recruit E3 ligases TRAF6 and Skp2-SCF for K63-linked ubiquitination and membrane recruitment. KDM4B demethylates this site. Mice with non-methylatable Akt1 show reduced body size and are less prone to carcinogen-induced tumors.\",\n      \"method\": \"In vitro methyltransferase assay, Co-immunoprecipitation, mass spectrometry, site-directed mutagenesis, knock-in mouse model, membrane fractionation\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic assay, mutagenesis, Co-IP of entire complex, in vivo knock-in mouse; independently replicated by two concurrent papers (Wang et al. and Guo et al.)\",\n      \"pmids\": [\"30692626\", \"30692625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"ATF7IP mediates SETDB1 nuclear retention by binding the N-terminal region (which contains nuclear export signals), and promotes its nuclear import. Nuclear localization of SETDB1 increases its ubiquitinated, enzymatically more active form.\",\n      \"method\": \"Co-immunoprecipitation, nuclear fractionation, leptomycin B treatment, ubiquitination assay, deletion constructs\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical methods establishing NES binding, nuclear retention, and correlation with ubiquitination/activity in single focused study\",\n      \"pmids\": [\"31576654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Drosophila Eggless/SETDB1 is monoubiquitinated in the nucleus, and this monoubiquitination is required for piRNA-mediated transposon repression. Windei (Wde, ortholog of ATF7IP) recruits Egg to chromatin at target gene silencing loci (Wde-independent nuclear import, but Wde-dependent chromatin targeting). Abundance of nuclear Egg is governed by that of nuclear Wde.\",\n      \"method\": \"Drosophila ovarian somatic cell system, monoubiquitination assay, nuclear import/chromatin recruitment assays, genetic knockdown\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — orthologous Drosophila system with direct biochemical demonstration of monoubiquitination requirement and chromatin recruitment mechanism; consistent with mammalian SETDB1 ubiquitination data\",\n      \"pmids\": [\"31576653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SETDB1 does not directly regulate Th1 gene promoter activity, but deposits H3K9me3 at a restricted, cell-type-specific set of ERVs located near genes involved in immune processes in T helper cells. Derepression of these ERVs upon Setdb1 deletion disrupts Th cell lineage integrity, enabling Th2 cells to cross lineage boundaries and acquire a Th1 phenotype.\",\n      \"method\": \"T cell-specific Setdb1 conditional KO, H3K9me3 ChIP-seq, RNA-seq, lineage differentiation assay\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with genome-wide ChIP-seq and transcriptomic analysis demonstrating ERV-mediated enhancer mechanism; multiple readouts\",\n      \"pmids\": [\"30737147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Maternal SETDB1 (and EHMT2) controls H3K9me3 levels in the maternal pronucleus, protecting maternal DNA from TET3-mediated 5mC oxidation (demethylation). Conditional deletion of the Setdb1 catalytic domain in oocytes significantly reduces H3K9me3 in the maternal pronucleus and increases 5hmC, 5fC, and 5caC levels there, reducing the normal 5mC oxidation asymmetry between pronuclei.\",\n      \"method\": \"Oocyte-specific conditional KO of catalytic domain, immunofluorescence for 5mC/5hmC/5fC/5caC, H3K9me2/3 ChIP\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — catalytic domain deletion demonstrates enzymatic requirement for H3K9me3-mediated 5mC protection, direct immunostaining of modified bases\",\n      \"pmids\": [\"31088968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Setdb1-null ES cells activate Dux and 2C-like state genes through loss of H3K9me3 at Setdb1 target loci. Dux is required for reactivation of 2C-like state genes upon Setdb1 deficiency. In 2i ground-state conditions, Setdb1-null cells activate Ripk3 and undergo RIPK1/RIPK3-dependent necroptosis.\",\n      \"method\": \"CRISPR Setdb1 KO in 2i and serum/LIF conditions, Dux KO epistasis, RNA-seq, H3K9me3 ChIP-seq, necroptosis inhibitor experiments\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with Dux KO, ChIP-seq, pathway inhibitor experiments, multiple conditions tested\",\n      \"pmids\": [\"31914391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Setdb1 regulates macrophage H3K9 methylation to suppress TLR4-mediated IL-6 expression. Setdb1-deficiency decreases basal H3K9 methylation and augments NF-κB recruitment to the IL-6 proximal promoter. Macrophage-specific Setdb1-KO mice show elevated serum IL-6 and increased susceptibility to endotoxin shock.\",\n      \"method\": \"Macrophage-specific conditional KO, ChIP (H3K9me3 and NF-κB at IL-6 promoter), in vivo LPS challenge\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO, ChIP demonstrating NF-κB displacement mechanism, in vivo functional validation\",\n      \"pmids\": [\"27349785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SETDB1 represses ERVs in intestinal epithelial cells via H3K9me3; loss of SETDB1 causes de-silencing of endogenous retroviruses, DNA damage, and intestinal epithelial cell death, leading to barrier disruption and inflammation.\",\n      \"method\": \"Constitutive and inducible intestinal epithelial Setdb1 conditional KO mouse, histology, DNA damage markers, ERV expression analysis\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined molecular (ERV derepression, DNA damage) and phenotypic (barrier disruption, inflammation) readouts\",\n      \"pmids\": [\"32503845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SETDB1 (as part of the HUSH/KAP1 complex) represses broad genomic domains enriched for transposable elements (TEs) and immune gene clusters. SETDB1 loss derepresses TE-derived regulatory elements, immunostimulatory genes, and TE-encoded retroviral antigens, triggering TE-specific cytotoxic T cell responses in vivo.\",\n      \"method\": \"In vivo CRISPR-Cas9 screen, ChIP-seq, RNA-seq, tumor immunology assays, immune checkpoint blockade experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo CRISPR screen plus extensive mechanistic follow-up with ChIP-seq, RNA-seq, and in vivo T cell response validation\",\n      \"pmids\": [\"33953401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The SETDB1-TRIM28 complex suppresses antitumor immunity. SETDB1-TRIM28 inhibition leads to micronuclei formation in the cytoplasm, which activates the cGAS-STING pathway. This simultaneously upregulates PD-L1 and increases CD8+ T cell infiltration, enhancing antitumor effects of anti-PD-L1 in a cGAS-dependent manner.\",\n      \"method\": \"CRISPR-Cas9 screen, SETDB1/TRIM28 KO, cGAS-STING pathway analysis, micronuclei quantification, in vivo tumor model\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic screen plus functional validation with cGAS-dependent in vivo rescue, mechanistic connection to micronuclei and STING activation\",\n      \"pmids\": [\"34848497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The SETDB1 tandem Tudor domain (TTD) recognizes histone H3 sequences containing both methylated and acetylated lysines. A selective small-molecule inhibitor (R,R)-59 occupies the TTD with KD 0.088 μM, as confirmed by co-crystal structure; the enantiomer (S,S)-59 is inactive.\",\n      \"method\": \"ITC binding assay, co-crystal structure of inhibitor–TTD complex, cellular target engagement assay\",\n      \"journal\": \"Angewandte Chemie\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with bound ligand, ITC quantification, stereochemical specificity validated; single lab\",\n      \"pmids\": [\"33511756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SETDB1 is required for homologous chromosome pairing and synapsis during meiotic prophase I in spermatocytes. Setdb1-null spermatocytes show aberrant centromere clustering, failure of bouquet formation, failed pairing/synapsis of homologs, and compromised meiotic sex chromosome inactivation (MSCI), leading to meiotic arrest and apoptosis.\",\n      \"method\": \"Spermatocyte-specific Setdb1 KO, cytological meiotic spread analysis, H3K9me3 ChIP, FISH, transcriptome analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with cytological and molecular analysis of meiotic stage-specific defects; complemented by Hirota et al. 2018 for MSCI mechanism\",\n      \"pmids\": [\"33406415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ATF7IP–SETDB1 disruption in tumor cells restores tumor antigen expression and derepresses ERVs, triggering a type I interferon response and T cell infiltration leading to immune-mediated tumor rejection.\",\n      \"method\": \"CRISPR-Cas9 suppressor screen, RNA-seq, SETDB1/ATF7IP KO, in vivo tumor rejection assay\",\n      \"journal\": \"Cancer immunology research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR screen plus functional in vivo validation with ERV derepression and interferon pathway activation\",\n      \"pmids\": [\"34462284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SETDB1 derepresses ERVs upon radiotherapy; SETDB1 loss enhances radiation-induced ERV expression, activates MDA5/MAVS signaling, and upregulates type I interferons, enhancing antitumor immunity and radiosensitization.\",\n      \"method\": \"Setdb1 genetic deletion, RNA-seq, ERV expression analysis, MDA5/MAVS pathway assay, in vivo radiotherapy mouse model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with pathway-specific readouts (MDA5/MAVS), in vivo validation, mechanistic pathway established\",\n      \"pmids\": [\"35648422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ATF7IP interacts with SETDB1 to regulate hematopoiesis in zebrafish through Setdb1-mediated H3K9me3 modification and chromatin remodeling. Interaction of ATF7IP and SETDB1 triggers H3K9me3 deposition at hematopoietic regulatory genes (cebpβ, cdkn1a), preventing premature myeloid differentiation and maintaining HSPC expansion.\",\n      \"method\": \"Zebrafish Atf7ip/Setdb1 mutants, H3K9me3 ChIP-seq, RNA-seq, retrotransposon assay\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — zebrafish genetic models with genome-wide ChIP-seq and pathway epistasis; specific target gene H3K9me3 validated\",\n      \"pmids\": [\"36577070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"H3K9me3 deposited by SETDB1 prevents aberrant CTCF binding at SINE B2 retrotransposon-enriched sites, independently of DNA methylation and H3K9me2. Loss of SETDB1 disrupts chromatin loops and local 3D interactions (but not overall TADs or subnuclear compartments), leading to transcriptional changes via altered cis-regulatory interactions.\",\n      \"method\": \"SETDB1 depletion in multiple mouse cell types, CTCF ChIP-seq, H3K9me3 ChIP-seq, Hi-C, ATAC-seq, DNA methylation analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide multi-omics in multiple cell types, epistasis with DNA methylation pathway, multiple orthogonal genome architecture methods\",\n      \"pmids\": [\"38167730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SETDB1 methylates MCT1 (monocarboxylate transporter 1) at K473 in vitro and in vivo. This methylation inhibits the interaction between MCT1 and Tollip, blocking Tollip-mediated autophagic degradation of MCT1, thereby stabilizing MCT1 and enhancing the lactate shuttle in colorectal cancer.\",\n      \"method\": \"In vitro methyltransferase assay, Co-immunoprecipitation, site-directed mutagenesis (K473), autophagy assay\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro methyltransferase assay on non-histone substrate with site-specific mutagenesis, Co-IP to define MCT1-Tollip interaction disruption; single lab\",\n      \"pmids\": [\"37541664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SETDB1 interacts with and methylates ASK1 (apoptosis signal-regulating kinase 1) at lysine residues, and this methylation promotes ASK1 phosphorylation and activation of downstream JNK/p38 signaling in hepatic ischemia-reperfusion injury. SETDB1 inhibition reduces ASK1 phosphorylation and downstream pathway activation; overexpression of ASK1 rescues this effect.\",\n      \"method\": \"Co-immunoprecipitation, in vitro methylation assay, ChIP, hepatocyte hypoxia/reoxygenation model, in vivo HIRI mouse model, rescue by ASK1 overexpression\",\n      \"journal\": \"Research (Washington D.C.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and methylation assay, rescue experiment; single lab, mechanistic details partially characterized\",\n      \"pmids\": [\"37915765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SETDB1 methylates CD147 at K71 (K71me2), and this modification promotes FOSB expression via enhanced p38 phosphorylation, leading to tumor cell apoptosis. SETDB1 was identified as the catalytic methyltransferase for this modification.\",\n      \"method\": \"Specific anti-CD147-K71me2 antibody generation, in vitro methyltransferase assay, site-directed mutagenesis (K71R), RNA-seq, p38 phosphorylation assay, in vivo xenograft\",\n      \"journal\": \"Genes & diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro methyltransferase assay with mutagenesis, but single lab with limited mechanistic validation of the K71me2-p38 link\",\n      \"pmids\": [\"37692516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SETDB1's Tudor domain (in a methyltransferase-independent manner) binds methylated RB (retinoblastoma protein) and protects CDK4/6-phosphorylated RB from TRIM28-mediated ubiquitination and proteasomal degradation. TRIM28 binds and promotes ubiquitination of CDK4/6-phosphorylated RB.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, SETDB1 Tudor domain mutant (methyltransferase-dead), antisense oligonucleotide knockdown, xenograft model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — methyltransferase-independent Tudor domain function established by catalytic mutant, Co-IP of TRIM28-RB complex, multiple biochemical and in vivo validation approaches\",\n      \"pmids\": [\"36637424\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ATF7IP2 is a meiosis-specific partner of SETDB1 (ortholog of ATF7IP). In ATF7IP2-null male mice, XY chromosomes lose obligatory crossovers, autosomal axis length increases and crossover number increases, meiotic DNA double-strand break formation/repair is affected, and spermatogenesis is blocked.\",\n      \"method\": \"ATF7IP2 KO mouse, Co-immunoprecipitation with SETDB1, cytological meiotic spread, ChIP for histone modifications\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP establishes SETDB1 partnership, KO phenotype defined, histone modification changes documented; single lab\",\n      \"pmids\": [\"37542719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SETDB1 is required for adult muscle stem cell (MuSC) regeneration. SETDB1 represses ERVs in MuSCs; ERV derepression in Setdb1-null MuSCs activates the cGAS-STING DNA-sensing pathway, induces cytokine expression, causes aberrant immune cell infiltration (histiocytosis), and prevents MuSC amplification, abolishing muscle repair.\",\n      \"method\": \"MuSC-specific Setdb1 KO, multi-omics (ATAC-seq, RNA-seq, ChIP-seq), cGAS-STING pathway analysis, intravital imaging, in vivo muscle regeneration model\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO with multi-omics and pathway-specific validation; cGAS-STING mechanism established\",\n      \"pmids\": [\"38848717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IRTKS recruits deubiquitinase OTUD4 to remove K48-linked polyubiquitin at K182/K1050 of SETDB1, blocking its proteasomal degradation, thereby increasing SETDB1 protein stability and H3K9me3 deposition. Enhanced SETDB1 activity suppresses CDH1 (E-cadherin) transcription via reduced chromatin accessibility, promoting EMT and tumor metastasis.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, site-directed mutagenesis (K182/K1050), ATAC-seq, ChIP-seq\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, site-specific ubiquitination sites defined by mutagenesis, functional consequence in ATAC-seq/ChIP-seq; single lab\",\n      \"pmids\": [\"37739210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"T cell-specific deletion of ESET/SETDB1 impairs thymocyte development, particularly CD8 lineage cells, through ectopic expression of FcγRIIB in ESET-null thymocytes. FcγRIIB signaling inhibits TCR-induced ERK activation. A KMT1E-containing complex directly interacts with the FcγRIIb promoter; H3K9me3 at this promoter is dependent on Setdb1. Genetic depletion of FcγRIIB in ESET-null thymocytes partially rescues defective positive selection.\",\n      \"method\": \"T cell-specific conditional KO, genome-wide mRNA/H3K9me3 profiling, ChIP at FcγRIIb promoter, double KO epistasis (ESET–FcγRIIb)\",\n      \"journal\": \"Journal of immunology; Genes and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double KO, direct ChIP at target promoter, two independent studies (Takikita et al. and Martin et al.) identifying same mechanism\",\n      \"pmids\": [\"27511731\", \"25569264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Monoallelic deletion of CBP leads to induction of ESET expression via elevated Ets-2 occupancy at the ESET promoter (CBP normally represses ESET transcription by limiting Ets-2 activity). Induced ESET increases H3K9 trimethylation and pericentric heterochromatin condensation in neurons.\",\n      \"method\": \"ESET promoter deletion/mutation analysis, luciferase reporter assay, ChIP (Ets-2 at ESET promoter), CBP siRNA, CBP+/- mouse model\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter mutational analysis, ChIP, and functional reporter assay establish transcriptional regulatory mechanism for ESET expression; single lab\",\n      \"pmids\": [\"18319327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In C. elegans (MET-2, SETDB1 homolog), MET-2 has a noncatalytic function that contributes to gene repression independently of H3K9me. Catalytically deficient MET-2 still forms subnuclear foci and maintains silencing of a subset of genes by blocking acetylation on H3K9 and H3K27. Under heat stress, MET-2 foci disperse, coinciding with derepression. LIN-61 is a cofactor required for this noncatalytic function.\",\n      \"method\": \"Catalytically dead MET-2 mutant analysis in C. elegans, immunofluorescence, H3K9me and acetylation ChIP, gene expression analysis\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — noncatalytic function proven by catalytic mutant in orthologous C. elegans system; chromatin acetylation blocking established\",\n      \"pmids\": [\"35102319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In C. elegans, the unstructured cofactor LIN-65 (along with ARLE-14) binds MET-2 (SETDB1 homolog). Ablation of lin-65 mislocalizes and destabilizes MET-2, resulting in decreased H3K9me2, dispersion of heterochromatic foci, and derepression of MET-2 targets. LIN-65 and MET-2 also maintain perinuclear anchoring of genomic heterochromatin.\",\n      \"method\": \"Mass spectrometry (cofactor identification), RNAi/genetic ablation, immunofluorescence, H3K9me2 ChIP, genome-wide expression analysis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS identification plus genetic ablation with multiple readouts; orthologous C. elegans system\",\n      \"pmids\": [\"30737265\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SETDB1 interacts with PELP1 (ER coregulator) in breast cancer cells, and PELP1 is required for SETDB1-mediated Akt methylation and phosphorylation. Knockdown of PELP1 abolishes SETDB1-mediated tamoxifen resistance and tumor progression in vivo.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, GST pulldown, in vitro methylation assay, xenograft model\",\n      \"journal\": \"Breast cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus GST pulldown plus Co-IP for interaction, in vitro methylation assay for functional consequence, in vivo rescue; single lab\",\n      \"pmids\": [\"35395812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ESET/SETDB1 is required for ESET-mediated repression of Runx2 transcriptional activity in osteoblasts; co-transfection of ESET represses Runx2-mediated luciferase reporter, and siRNA knockdown activates it. ESET deletion severely impairs osteoblast differentiation and is required for Indian hedgehog expression in the growth plate.\",\n      \"method\": \"ESET mesenchyme-specific conditional KO, luciferase reporter (Runx2-mediated), siRNA knockdown\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo KO with defined differentiation phenotype, reporter assay demonstrating Runx2 repression; single lab\",\n      \"pmids\": [\"24188826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Drosophila SETDB1 (dSETDB1) tri-methylates H3-K9, binds methylated CpA motifs, and recruits DNA methyltransferase Dnmt2 and HP1 (Su(var)205) to trigger DNA methylation and silencing of target genes and retrotransposons. dSETDB1 is involved in postembryonic DNA methylation of retrotransposons and the tumor suppressor Rb in imaginal discs.\",\n      \"method\": \"Drosophila cell culture, in vitro H3-K9 methyltransferase assay, DNA methylation assay, ChIP, RNAi knockdown\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro enzymatic assay plus ChIP and RNAi in Drosophila system; orthologous but distinct DNA methylation mechanism from mammals\",\n      \"pmids\": [\"20498723\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SETDB1 is a euchromatic histone H3K9 methyltransferase (requiring its SET domain for catalytic activity) that deposits H3K9me2/3 to silence endogenous retroviruses/transposable elements, developmental genes, and select tissue-specific loci; it operates in complexes with KAP1/TRIM28, ATF7IP, KRAB-ZFPs, and OCT4, is recruited to chromatin partly via its tandem Tudor domain, regulated by ATF7IP-dependent nuclear retention and monoubiquitination, and also methylates non-histone substrates including AKT (K64), p53 (K370), UBF (K232/254), MCT1 (K473), ASK1, and CD147 (K71) to modulate their stability or activity in development and cancer.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SETDB1 (ESET/KMT1E) is a SET-domain histone H3 lysine 9 methyltransferase that deposits H3K9me2/3 to establish and maintain repressive chromatin across endogenous retroviruses, transposable elements, developmental regulators, and lineage-restricted loci, and is essential for peri-implantation development and ES cell survival [#0, #1, #6]. Its core silencing activity is exerted within complexes nucleated by KAP1/TRIM28 and sequence-specific KRAB-zinc-finger proteins, which target SETDB1 to retroviral and transposon sequences for H3K9me3 deposition and HP1 binding in a DNA-methylation-independent manner [#6, #9, #31]; SETDB1 also bridges to the de novo DNA methylation machinery (DNMT3A/3B) and other recruiters including OCT4, KDM5B, SMAD3, and AGO2 to silence developmental, lineage, and tissue-specific targets [#2, #3, #14, #20, #22]. Loss of SETDB1 derepresses ERVs and transposons, which generates cytosolic nucleic acids that activate cGAS-STING and MDA5/MAVS sensing and a type I interferon response — a mechanism that drives antitumor immunity but also causes DNA damage and cell death in epithelia, muscle stem cells, and ground-state ES cells [#22, #28, #30, #31, #36, #44]. Beyond histone substrates, SETDB1 methylates non-histone proteins to control their stability and signaling, including p53 K370me2 (limiting MDM2-mediated degradation) [#17], UBF (repressing rDNA transcription) [#13], AKT K64 (enabling membrane recruitment and activation) [#23], and MCT1 K473 (blocking autophagic degradation) [#39]. SETDB1 silencing also organizes 3D genome architecture, with H3K9me3 at SINE/B2 and protocadherin-locus elements excluding aberrant CTCF binding to preserve chromatin loop topology [#19, #38]. SETDB1 abundance, nuclear retention, and activity are regulated by ATF7IP-dependent nuclear import coupled to ubiquitination and by monoubiquitination of the enzyme [#10, #24, #25], and its tandem Tudor domain reads dual methyl/acetyl histone marks and, independently of catalysis, stabilizes phosphorylated RB against TRIM28-mediated degradation [#33, #42].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing SETDB1 as a bona fide enzyme answered what biochemical activity it carries: it is a SET-domain-dependent H3K9 methyltransferase that also physically partners with a sequence-specific transcription factor.\",\n      \"evidence\": \"In vitro HMT assay with SET-domain active-site mutagenesis plus GST pulldown/Co-IP with ERG\",\n      \"pmids\": [\"11791185\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define genome-wide targets\", \"Mechanism of chromatin recruitment unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Genetic knockout established that SETDB1 is non-redundantly required for early embryogenesis and ES cell viability, placing its H3K9 methylation activity at the center of pluripotency maintenance.\",\n      \"evidence\": \"Mouse homozygous knockout with lacZ reporter and immunofluorescence localization to euchromatin\",\n      \"pmids\": [\"14993285\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the silenced loci responsible for lethality\", \"No catalytic-versus-structural requirement test\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linking SETDB1 to de novo DNA methyltransferases showed how H3K9 methylation is coordinated with DNA methylation at silenced promoters.\",\n      \"evidence\": \"Co-IP/GST pulldown with DNMT3A/3B (not DNMT1), Gal4-tethering reporter, and ChIP at endogenous CpG-methylated promoters\",\n      \"pmids\": [\"16682412\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Causal order of H3K9me and DNA methylation not resolved here\", \"Generality across loci untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identifying OCT4 and the KRAB-ZFP/KAP1 axis as recruiters defined how SETDB1 is targeted to lineage genes and proviruses, and showed SETDB1 represses developmental/bivalent genes.\",\n      \"evidence\": \"Reciprocal Co-IP with SUMO-dependent OCT4 binding, ChIP-seq, shRNA and blastocyst injection\",\n      \"pmids\": [\"19884257\", \"19811652\", \"19884255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SUMO/SIM recognition integrates with catalytic targeting unclear\", \"Distinction of direct vs indirect targets incomplete\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating KAP1/TRIM28-dependent, DNA-methylation-independent retroviral silencing established SETDB1 as the principal H3K9me3 writer for ERV/proviral repression in ES cells.\",\n      \"evidence\": \"Conditional KO/shRNA, retroviral silencing assays, ChIP, and epistasis in Dnmt triple-KO ES cells\",\n      \"pmids\": [\"20164836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specificity determinants distinguishing SETDB1 from other H3K9 KMTs not fully mapped\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Comparing SETDB1- and DNMT-dependent derepression showed the two pathways silence largely non-overlapping ERV sets and that ERV derepression rewires host transcription via chimeric transcripts.\",\n      \"evidence\": \"Conditional KO with RNA-seq/ChIP-seq versus Dnmt1/3a/3b triple-KO mESCs\",\n      \"pmids\": [\"21624812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequences of individual chimeric transcripts unexplored\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extending the KRAB-ZFP–KAP1–SETDB1 module to de novo DNA methylation and to non-histone substrate methylation (UBF) broadened SETDB1's mechanistic scope beyond histone silencing.\",\n      \"evidence\": \"ES cell ERV reporter with bisulfite/ChIP and KAP1 KO; separately in vitro UBF methylation with mutagenesis and AFM\",\n      \"pmids\": [\"23293284\", \"24234436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the same enzyme pool serves histone and non-histone substrates unknown\", \"Recruitment to rDNA not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defining ATF7IP-dependent nuclear retention and ubiquitination established a key regulatory layer controlling where and how active SETDB1 is.\",\n      \"evidence\": \"Co-IP, deletion mapping of N-terminal NES region, leptomycin B, ubiquitination assays, nuclear fractionation\",\n      \"pmids\": [\"31576654\", \"23782009\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the E3 ligase(s) for activating ubiquitination not established\", \"Link between ubiquitination state and catalytic rate quantitative mechanism unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mapping SETDB1 into additional silencing complexes (SIN3A/HDAC, EZH2/Polycomb, SMAD2/3) and pathways (XCI maintenance, agRNA silencing, metastasis suppression) showed the breadth of contexts that co-opt its H3K9me3 activity.\",\n      \"evidence\": \"RNAi/ChIP/Co-IP for AGO2 and SIN3-HDAC; siRNA epistasis for MBD1–ATF7IP–SETDB1 in XCI; in vivo metastasis with SMAD2/3 Co-IP\",\n      \"pmids\": [\"25183519\", \"25028596\", \"25477335\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect partnerships not all reciprocally validated\", \"Single-lab observations for several axes\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying p53 K370 dimethylation revealed SETDB1 as a regulator of tumor suppressor stability, connecting its catalytic activity to cancer signaling.\",\n      \"evidence\": \"Co-IP, in vitro methyltransferase assay, siRNA, MDM2-degradation assay\",\n      \"pmids\": [\"26471002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of p53-K370me2 not addressed here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Catalytic-mutant rescue in oocytes proved enzymatic activity is required for SETDB1's developmental functions, and lineage-/tissue-specific KOs (thymocytes, macrophages) showed locus-specific repression underlies distinct cell-fate and immune phenotypes.\",\n      \"evidence\": \"Oocyte conditional catalytic-domain KO with WT vs catalytically dead rescue; T cell and macrophage conditional KOs with target-promoter ChIP and epistasis\",\n      \"pmids\": [\"27070551\", \"27317807\", \"27511731\", \"25569264\", \"27349785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How distinct target sets are selected in different cell types unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating SETDB1 control of 3D genome topology at the protocadherin TAD and its recruitment by SMAD3 to repress SNAI1 expanded its role from sequence-level silencing to chromatin architecture and signaling-coupled gene control.\",\n      \"evidence\": \"Neuron-specific KO with Hi-C/ChIP-seq/bisulfite; Co-IP/ChIP/reporter for Smad3–SETDB1 at SNAI1\",\n      \"pmids\": [\"28671686\", \"29233829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CTCF exclusion is a direct H3K9me3 effect or secondary not fully separated here\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Placing SETDB1 downstream of the meiotic DNA damage response via TRIM28 explained how H3K9me3 accumulates on the sex chromosomes to drive meiotic silencing.\",\n      \"evidence\": \"Spermatocyte conditional KO with ChIP, immunofluorescence, and proteomic identification of TRIM28 bridge\",\n      \"pmids\": [\"30393076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular signal coupling DDR to TRIM28–SETDB1 recruitment not fully defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A burst of studies established SETDB1's non-histone methylation of AKT (K64) driving its activation, refined ATF7IP/Wde-dependent nuclear retention and monoubiquitination control, and showed ERV derepression activates innate immunity and necroptosis/Dux-driven 2C states upon SETDB1 loss.\",\n      \"evidence\": \"In vitro methylation + knock-in mouse for AKT; Drosophila/mammalian ubiquitination and nuclear-retention assays; CRISPR KO with RNA-seq/ChIP-seq, KDM5B recruitment, and Dux epistasis\",\n      \"pmids\": [\"30692626\", \"30692625\", \"31576654\", \"31576653\", \"34671158\", \"31914391\", \"31088968\", \"30737147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether non-histone and histone activities are coordinately regulated unknown\", \"Recruitment specificity to immune-proximal ERVs incompletely defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"In vivo CRISPR screens established SETDB1-TRIM28/HUSH/ATF7IP as a repressor of immunostimulatory transposons and antigens whose loss triggers cGAS-STING/interferon-mediated antitumor immunity, while structural work defined the tandem Tudor domain as a druggable reader of dual methyl/acetyl histone marks.\",\n      \"evidence\": \"In vivo CRISPR screens with ChIP-seq/RNA-seq and immune-checkpoint experiments; ITC and co-crystal structure of TTD inhibitor; meiotic KO cytology\",\n      \"pmids\": [\"33953401\", \"34848497\", \"34462284\", \"33511756\", \"33406415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TTD reader function's contribution to silencing vs catalysis not fully separated\", \"Therapeutic window of TTD inhibition untested in this corpus\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mechanistic studies tied SETDB1-deposited H3K9me3 to CTCF exclusion at SINE B2 elements controlling chromatin loops, and extended the ERV-derepression/interferon axis to radiotherapy sensitization and hematopoiesis.\",\n      \"evidence\": \"Multi-omics (CTCF/H3K9me3 ChIP-seq, Hi-C, ATAC-seq) with DNA-methylation epistasis; in vivo radiotherapy model; zebrafish ATF7IP/Setdb1 mutants\",\n      \"pmids\": [\"38167730\", \"35648422\", \"36577070\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mechanism by which H3K9me3 blocks CTCF binding biochemically unresolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"New non-histone substrates (MCT1, ASK1, CD147) and a catalysis-independent Tudor function (RB stabilization) expanded SETDB1 into a regulator of metabolism, stress signaling, and the cell cycle beyond chromatin silencing.\",\n      \"evidence\": \"In vitro methylation with site-directed mutagenesis and Co-IP for MCT1/ASK1/CD147; catalytic-dead Tudor mutant and ubiquitination assays for RB-TRIM28; IRTKS/OTUD4 stability axis\",\n      \"pmids\": [\"37541664\", \"37915765\", \"37692516\", \"36637424\", \"37739210\", \"37542719\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Several substrate findings are single-lab\", \"Physiological stoichiometry and in vivo relevance of some non-histone methylation events untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Tissue-specific KO confirmed that SETDB1-mediated ERV repression is required for adult stem-cell function, with derepression triggering cGAS-STING-driven inflammation that blocks regeneration.\",\n      \"evidence\": \"MuSC-specific KO with ATAC/RNA/ChIP-seq, cGAS-STING analysis, and in vivo regeneration model\",\n      \"pmids\": [\"38848717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether interferon induction or DNA damage dominates the regenerative failure not fully dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SETDB1 partitions its activity between H3K9 methylation, non-histone substrate methylation, and catalysis-independent Tudor reader functions — and how recruitment selects among ERVs, developmental genes, and non-histone targets — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model coupling cofactor binding to substrate choice\", \"Determinants of locus selectivity among many KRAB-ZFP/cofactor inputs unknown\", \"Structure-function relationship of catalytic vs Tudor activities in vivo not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 6, 13, 17, 23, 39]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [17, 23, 39, 13]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [33]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [5, 6, 20]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 10, 24]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [5, 6, 19, 38]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 6, 19, 38]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [5, 20, 46]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 3, 18, 34]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [22, 26, 31, 36, 44]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 17, 23, 45]}\n    ],\n    \"complexes\": [\"KAP1/TRIM28-SETDB1 complex\", \"HUSH complex\", \"ATF7IP-SETDB1 complex\", \"SIN3-HDAC complex\"],\n    \"partners\": [\"TRIM28\", \"ATF7IP\", \"OCT4\", \"DNMT3A\", \"KDM5B\", \"SMAD3\", \"ERG\", \"PELP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}